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Abstract 
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EXECUTIVE SUMMARY 
 
The Government’s Improving Access to Psychological Therapy (IAPT) programme 
aims to implement NICE Guidance for people with depression and anxiety disorders. 
In the first phase of the programme, two demonstration sites were established in 
Doncaster and Newham with funding to provide increased availability of cognitive-
behaviour therapy-based (CBT) services to those in the community who need them. 
The services opened in late summer 2006. This report documents the achievements 
of the sites up to September 2007 (roughly their first year of operation) and makes 
recommendations for the future roll out of IAPT services.  
 
 
Funding 
 
Each site received £1.3-1.5 million in extra resource. 
 
 
Clinical Populations 
 
The clinical populations served by the two sites are different. Doncaster focuses 
predominantly on individuals for whom depression is considered by their GPs to be 
their main problem, although many are also considered to have generalized anxiety 
disorder. Post-traumatic stress disorder and obsessive-compulsive disorder are 
excluded. Newham focuses on depression and all anxiety disorders. Individuals seen 
in Doncaster are predominantly white, whereas Newham has an ethnically mixed 
population with a substantial number who do not speak English. 
 
 
Services 
 
The clinical services in both sites are based on NICE Guidelines, but have somewhat 
different emphases. Doncaster is described as a high throughput, stepped care 
service with a marked emphasis on low intensity work (especially guided self-help), 
although high intensity work is also available. Newham places a greater emphasis on 
high intensity CBT but over time has increased its capacity to deliver low intensity 
interventions for the conditions where they are indicated. 
 
Outcomes are mainly assessed by patient self-report. Brief, standardized 
questionnaires measuring depression (the PHQ) and anxiety (the GAD) are given at 
every session. A longer symptom questionnaire (CORE-OM) plus measures of 
employment and other variables are intended to be given at pre-treatment, formal 
review sessions, and at post-treatment. The services do not routinely collect follow-
up data but the evaluation team conducted a further assessment at a minimum of 
four months after patients left the services. 
 
Multiple sources of referral are available. Many patients are referred by their GPs but 
referrals from Job Centre Plus, other professionals and self-referral are also 
encouraged. 
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Achievements 
 
Despite being new starts, both demonstration sites have achieved a great deal in 
their first thirteen months, much to the credit of their highly enthusiastic and 
dedicated staff.  
 
1. Numbers treated. An impressive number of people have been assessed and 
treated by the sites. During the thirteen months covered by this report nearly 
5,500 people have been referred, of whom 3,500 have concluded their 
involvement with the services. Around 1,900 of the concluded cases received 
at least 2 sessions of treatment. The numbers seen in Doncaster are 
particularly impressive. 
2. Completeness of outcome monitoring. Session by session use of the  PHQ 
and GAD has ensured that the sites have almost complete data on pre to 
post-treatment changes in depression and anxiety (99% of treated cases in 
Doncaster and 88% in Newham, despite the significant number of people who 
do not speak English). Data completeness is less impressive (56% or less) for 
measures that were only intended to be collected at pre- treatment and post-
treatment.   
3. Psychological Benefits. Both demonstration sites achieved good recovery 
rates (52%) for people who had depression and/or an anxiety disorder for 
more than 6 months. These results confirm that CBT in the field can deliver 
short-term results broadly in line with those observed in the clinical trials that 
are the basis for the NICE Guidelines. Furthermore, the follow-up study 
suggests that these gains are largely maintained 4-12 months later. A minority 
of people had been unwell for less than 6 months when they entered the 
services. Although these individuals showed at least as large gains, it is 
difficult to know whether this represents a significant added benefit from the 
service as natural recovery and recovery following modest treatment as usual 
in primary care can also be high in such individuals.  
4. Employment Effects. At the end of treatment 5% more of the treated 
population was in employment (range 4% to 10%). This is supportive of the 
assumptions made in Department of Health’s 2007 Comprehensive Spending 
Review proposal. 
5. Self-referral. Approximately one in five people seen in Newham referred 
themselves to the service. Providing a self-referral route appears to have 
enabled the service to access disabled individuals in the community who are 
not well served by existing referral routes. Compared to GP referrals, self-
referrers are at least as unwell, tend to have had their problems for longer, 
and more closely match the ethnic mix of the community. 
 
 
Recommendations 
 
Much can be learned from the pioneering work of the demonstration sites. For the 
future rollout of IAPT services we recommend: 
 
1. More extensive use of session-by-session outcome measurement. 
Completeness of data for determining the benefits of the services was much 
higher for variables (depression & anxiety) that were assessed every session 
  3
than for variables that were meant to be assessed at pre-treatment and post-
treatment only. In addition, there is evidence that individuals who complete 
these pre and post-treatment only measures tend to show more clinical 
improvement, which suggests that such measures may over-estimate benefit. 
It is therefore recommended that future IAPT services aim to also include brief 
measures of employment and disability in their session-by-session 
assessments. 
2. Accept Self-referrals. The findings from Newham indicate that allowing self-
referral enables services to access individuals with chronic and disabling 
conditions who are not well served by existing GP only referral systems.  
3. Include a brief diagnostic assessment. Nice guidance varies between the 
different disorders covered by the IAPT initiative. In order to establish which 
guidance is relevant, a diagnosis needs to be established on entry to the 
services.   
4. Provide clear criteria and sufficient capacity for patients to be stepped 
between low intensity and high intensity interventions, if required. Nice 
Guidelines indicate that when low intensity interventions are recommended 
within a stepped care approach, patients who fail to adequately respond to 
such interventions need to be offered a subsequent step-up to high intensity 
intervention. Step down from high to low interventions is also sometimes 
appropriate. For stepping to work effectively, services need to have clear 
stepping criteria; the two types of intervention need to be described to patients 
as equally valid, but different; and there needs to be sufficient therapist 
capacity at each level.  
5. Planned Follow-up. Depression is a recurring problem. Part of the appeal of 
psychological treatments is that they have the potential to achieve enduring 
effects. Such effects need to be demonstrated, rather than assumed. We 
therefore recommend that IAPT services include a routine follow-up 3-6 
months after treatment completion and offer a few sessions of booster 
treatment at that stage if there are signs of deterioration. Routine inclusion of 
relapse prevention procedures in the treatment programmes should also be 
considered. 
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INTRODUCTION 
 
In late 2005 the government established the Improving Access to Psychological 
Therapy (IAPT) programme to develop proposals for implementing the NICE 
Guidelines for people with depression and anxiety disorders. As part of this process, 
two demonstration sites were established in Doncaster and Newham, to provide 
cognitive behavioural therapy-based (CBT) services to those in the community who 
need them and in doing so to throw light on fruitful patterns of national roll-out.  
  
The services opened in late summer 2006. In this report we document the 
achievements of the two sites up to end September 2007. This covers roughly the 
first year of operation, during which both sites were starting from scratch. A fuller 
evaluation based at the University of Sheffield and supported by the National 
Institute for Health Research Service Delivery and Organisation (SDO) will be 
following patients over a much longer period and using more sophisticated research 
methods than were possible in the short time available for our own enquiry. 
 
In what follows, we treat the two sites in turn and then draw some general 
conclusions. For each site we begin with organisation – a general description of the 
service offered, the system of referral, and the pattern of staffing. We then trace the 
progress of patients – numbers treated and for how long. Next we examine the 
psychological outcome of the treatment – comparing scores on assessment tools 
before and after treatment; and then we do the same for employment outcomes. We 
also report on a follow-up of outcomes four or more months after the end of 
treatment. Finally we present the funding of each site, and examine its activity in 
relation to the overall pattern of need in the local area. 
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1. DONCASTER 
 
ORGANISATION 
 
The Doncaster service describes itself as a high-volume, predominantly low-intensity 
service, based on a stepped care model. Proposals for such a service were being 
developed from 2005 onwards. At this time also, moves towards a stepped care 
model were being taken with the employment of six graduate mental health workers 
in Doncaster. 
 
The IAPT demonstration site itself went live mid-August 2006. The six graduate 
mental health workers were integrated into IAPT as case managers, and referrals to 
some other primary care mental health services, such as the Doncaster Primary 
Care Trust counselling service, became coordinated via the IAPT. 
 
The central activity of the service is individual case management, largely telephone 
based, which offers patients guided self help and support based on CBT principles. It 
is possible for patients to be referred onward within the service to specialist CBT 
therapy, or counselling. The service design draws strongly on the collaborative care 
framework. 
 
 
Referrals 
 
GPs are asked to refer to the service 
a) “All patients with at least moderate depression (PHQ9 of 10 or more) except 
those with a history of repeated treatment failure, psychotic features, 
personality disorder, primary drug/alcohol problems, or significant risk.” 
b) “All patients with GAD [generalised anxiety disorder] (usually scoring more 
than 10 on GAD7), panic disorder (with or without agoraphobia), simple 
phobias, social phobia, and health anxiety, except those with significant 
suicide risk” or who “have failed to respond to at least 3 interventions”1. 
More serious cases are to be referred to specialised secondary mental health 
services as are all cases of post-traumatic stress disorder and obsessive-compulsive 
disorder. 
 
Referral sources: 
• GP: 96% 
• Other health professional: 3% 
• Self-referral and Jobcentre Plus referral: <1% 
Interestingly there were almost no referrals recorded as received via Jobcentre 
Plus2, although the Doncaster area has a Pathways to Work programme, and each 
Jobcentre Plus has an IAPT case manager liaising with it. It is possible that patients 
who hear about IAPT via Jobcentre Plus are formally referred via other routes. 
                                                   
1 Quoted from Doncaster’s ‘GP Referral Pack to IAPT’. 
2 16 referrals came from Jobcentre Plus. There were 11 self-referrals.  
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Personal characteristics of those referred: 
• 65% are women 
• 99.1% are ‘White British’ (99.5% ‘White’) 
• 16% are aged 18-24, 52% are aged 25-44 and 28% are aged 45-64. Numbers 
over 65 are very low (3%) as service focus is on working age adults. 
 
Diagnosis. No formal diagnosis of patient problems is undertaken by the IAPT 
service. Instead, patient diagnoses are taken directly from GP referral forms. The 
guidelines given to GPs suggest using the PHQ-9 and GAD-7 to support diagnosis; 
GPs do not ordinarily use formal assessment methods based in standardised 
psychiatric diagnostic criteria (e.g. ICD10 or DSM-IV). 
 
In GPs’ assessments of the patients they referred, almost all had depression as their 
primary problem: 
• 95% Depression 
• 5% Anxiety disorders, comprised of: 
o 3.9% Generalized Anxiety Disorder 
o 0.4% Agoraphobia ‘with panic’ 
o 0.1% Agoraphobia ‘no panic’ 
o 0.3% Social phobia 
o 0.2% PTSD 
o 0.2% Specific phobia 
o 0.1% OCD 
o <0.1% Health anxiety 
• <1% Other (includes bereavement, eating disorder, drug/alcohol problem) 
 
In GPs’ assessments, most of the patients referred had multiple problems: 90% had 
more than one problem recorded. Among those with multiple problems recorded, the 
most common secondary problem was an anxiety disorder: 
• 97% Anxiety disorders, comprised of: 
o 96.6% General anxiety disorder 
o 0.4% Agoraphobia 
o 0.2% Social phobia 
o 0.1% PTSD 
o 0.1% OCD 
o <0.1% Specific phobia 
o <0.1% Health anxiety 
• 2% Depression 
• 1% Other (includes bereavement, eating disorder, drug/alcohol problem) 
 
While GPs assessed only 5% of the patients they referred to the service as primarily 
suffering from anxiety disorders, the relative rate of detection of anxiety disorders 
among GPs in Doncaster is 21% (to depression’s 79%) (Chan et al, 2008). It 
therefore appears that the Doncaster service is primarily a service for depression, 
generalized anxiety disorder, and mixed anxiety and depression. Other anxiety 
disorders that are covered by the IAPT initiative and are common in the community 
such as panic disorder, agoraphobia, and social phobia do not appear to have been 
prominent in the service, while OCD and PTSD are referred directly to secondary 
mental health services. 
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Severity. At the first meeting with IAPT services the severity of individuals’ 
symptoms are indexed using the PHQ-9 and GAD-7 measures. The distribution of 
severity ratings were as follows:  
• PHQ-9: 
o 6% score 0-4 
o 12% score 5-9 
o 20% score 10-14 
o 28% score 15-19 
o 34% score 20+ 
• GAD-7: 
o 6% score 0-4 
o 15% score 5-9 
o 27% score 10-14 
o 52% score 15+ 
 
For the purposes of this report, patients are considered to be a clinical ‘case’ if they 
score above certain values on PHQ-9, and/or the GAD-7. For the PHQ-9, a score of 
10 or over indicates clinical caseness; for the GAD-7, recent research indicates a 
score of 8 or over indicates clinical caseness (Kroenke et al, 2002; 2007). On this 
basis, 90% of the referred individuals are clinical cases. 
 
Duration. GPs are not asked to wait for any period before referring a person to the 
service. Duration distributions are 3: 
• 33% had this episode for less than 6 months 
• 33% had this episode for between 6 months and 2 years 
• 34% had this episode for 2 years or more. 
The median duration of the presenting problem is 0.9 years and the mean 2.9 
years4. 
 
Medication. An estimated 55% of the people referred to the service are taking 
psychotropic medication at intake5. Among those taking medications, the types taken 
were: 
• 71% SSRI 
• 5% tricyclic 
• 3% beta-blocker 
• 3% hypnotic 
• 1 % antipsychotic 
• <1% MAOI 
• <1% antimanic 
• 18% unknown or other 
 
 
 
                                                   
3 This is of the 53% of referrals who have duration recorded. See the section on psychological 
outcomes for further discussion of the importance of the duration issue. 
4 The duration recording is intended to capture the duration to date of the current episode of illness. 
However, data inspection suggests that in some cases the recording may have been of the total 
lifetime history of illness, with the furthest outlier being a duration of 55 years. 
5 This is of the 63% who have medication data recorded. 
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Staff 
 
Within IAPT: The largest group of staff working in the service are 20 case managers 
– people with a variety of backgrounds6 who receive graduate or post-graduate 
training in primary mental health care provided by York University (one week 
intensive clinical skills training, then two terms of one day a week classroom-based 
training and one day a week practical training supervised by York University)7. 
 
The case managers operate within a structured supervision framework. Supervision 
takes place weekly and lasts for around 1 hour. It is provided by CBT therapists 
employed by IAPT. The decision of which patients to take to supervision is 
automated – it includes all with high PHQ-9 / GAD-7 scores, and also every patient 
after every 4th session. Case managers also have open access to CBT therapists on 
a daily basis to discuss patient treatments and risks as needed.  
 
If case managers find a case needs more intensive CBT therapy, after adequate 
treatment duration at lower treatment steps, they can transfer the patient to one of 
the CBT therapists employed in the IAPT project. The CBT therapists each spend 
one day a week on supervision of case managers and one day acting as the service 
‘duty manager’, with the remaining three days for clinical work. IAPT is funded for 4 
CBT therapists but has operated with fewer over the period covered by this report 
(see below for details). 
 
The numbers of staff have inevitably varied over time. In September 2007 IAPT 
employed the following numbers (FTE):  
 
                                                   
6 6 of the case managers were previously employed in Doncaster as graduate mental health workers. 
Common backgrounds of the other case managers include counselling diplomas, psychology 
degrees, professionals from other social services such as social work and occupational therapy, and 
‘experts by experience’. 
7 The level of training depends on the prior qualifications of the person – those who are non-graduates 
(prior to this) receive modules at third-year undergraduate level; others receive the same modules at 
postgraduate level. All attend all training modules, and all are assessed on their clinical competency; 
some also undertake academic assignments. 
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Staff type Total FTE: (Which includes 
vacant:) 
Directors (clinical and project) 
- Pay bands 8c-d 
1.5 (1) 
Team manager 
- Pay band 7 
1 (0) 
Lead counsellor 
- Pay band 6 
0.5 (0) 
CBT therapists 
- Pay bands 6-7 
4.0 (1.7)8 
Case managers  
- Pay bands 4-5 
20.59 (2.3) 
Administrative staff 
- Pay bands 3-4 
4 (1) 
Total 31.5 (6) 
 
Associated with IAPT: In addition to the case managers and CBT therapists 
employed directly by the IAPT, there are five counsellors who are managed by the 
IAPT team manager but funded by Doncaster Primary Care Trust10. 
 
Prior to the implementation of IAPT GPs would have referred patients to these 
counsellors directly. Now the referral pathway is via IAPT. These counsellors are 
focussed on Doncaster west; there is another counselling service working for 
Doncaster PCT in central and east Doncaster (AB Counselling) who retain their 
original referral pathway via GPs in the practices where they are based, as well as 
accepting referrals from IAPT. 
 
Case managers are able to refer patients to counsellors in the same manner as they 
would refer them to a CBT therapist. The counsellors offer both brief focussed 
counselling and longer-term counselling (usually 6-12 sessions but this can be 
extended further), and are classified by IAPT as offering both low and high intensity 
services at levels 2 and 3 of the Doncaster stepped care model. 
 
 However, the counsellors remain outside of the IAPT service itself in as much as 
they are not funded by IAPT, do not use the same IT system to manage patient flows 
and treatment, and are not subject to the same data collection requirements. 
Patients’ activities with the counsellors are not included in the IAPT patient records 
that are the basis of this evaluation. The treatment outcomes analysed here are for 
the IAPT case managers and CBT therapists only. 
 
Mental Health Trust (external to IAPT): To complete the picture of psychological / 
counselling services in Doncaster we can add the following employees of the 
Rotherham, Doncaster and South Humber Mental Health NHS Foundation Trust 
(RDaSH): 
                                                   
8 The vacant CBT posts were filled in December 2007 and January 2008. 
9 Six of these are funded by Doncaster PCT, with the funding that was previously used to employ 
graduate mental health workers to work in GP practices. 
10 To be more precise, the Doncaster PCT funds 4.93 FTE counsellor positions; 0.5 of this goes to 
funding a lead counsellor. This lead counsellor is also 0.5 funded by IAPT directly as detailed in the 
staffing table above. 
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Staff type Total FTE: (Which includes 
vacant:) 
Cognitive behavioural 
psychotherapists 
5.4 (0) 
Clinical psychologists 2.4 (1.6) 
Counsellors  2.7 (0) 
Total 10.5 (1.6) 
 
The RDaSH operates on the assumption that each year it will accept around 133 
patients for specialist (face-to-face) CBT, with a waiting time of 14-20 months. This 
capacity is largely used for more seriously ill patients and not for patients who have 
been stepped up through IAPT; RDaSH assumes a further 40-80 patients will be 
seen each year for specialist CBT within the IAPT team. 
 
The low volumes of CBT within RDaSH are due to higher intensity of treatment. 
Planned average hours per patient treated are 17 for RDaSH cognitive behavioural 
psychotherapists (with a throughput per therapist of 27 per annum). For comparison, 
RDaSH assumes IAPT case managers will average 4 hours per patient treated. 
 
The RDaSH counselling service operates on the assumption that each year it will 
accept around 114 patients, with each patient being treated for an average of 12 
hours. The RDaSH clinical psychologists operate on a planned 36 patients accepted 
per annum, with 20 hours per patient. 
 
 
Treatment 
 
The normal mode of treatment is for a patient referred to the service to be contacted 
immediately and first seen by a case manager about 21 days later11, face-to-face, for 
45 minutes to an hour, at a venue of their choice which is often on the GP’s 
premises. This first session, when the patient first completes the standard 
questionnaires, leads to an assessment of the patient’s problem (but no formal 
diagnosis) followed by the beginning of treatment.  
 
The patient’s beliefs, attitudes and behaviour are analysed, and a treatment plan 
including goals for the future are agreed. Typically a patient receives a copy of ‘A 
Recovery Programme for Depression’ by Karina Lovell and David Richards, while 
42% are also given Chris Williams’ ‘Overcoming Anxiety’. The case manager and 
patient will schedule a next meeting and agree on section(s) of the book for the 
patient to work through prior to that. At the next meeting they will reflect on that work, 
and agree on further work as needed, and so on. 
 
Subsequent sessions are held on the telephone. Patients who do not phone in at the 
appointed time are proactively followed up as agreed at onset of treatment. Patients 
are also offered the alternative of face-to-face meetings. (Around 23% of subsequent 
meetings are face-to-face, which last on average 40 minutes.) 
 
                                                   
11 Median value. Interquartile range is from 13 to 33 days. 
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The average telephone session lasts 22 minutes. The case manager works with a 
computer, using an IT system designed to help manage and track patient treatment. 
The session begins with the case manager administering the PHQ-9 and GAD-7 
over the phone. The patient answers the questions and the case manager records 
the answers on her computer. The majority of the session involves therapeutic 
engagement: discussion of the patient’s current situation, reflection on progress, and 
agreeing a next piece of work as appropriate.  
 
If the patient makes sufficient progress, treatment is discontinued by agreement. If 
the symptoms fail to improve, additional treatment options at the same intensity level 
are discussed and may be undertaken by the patient if appropriate; or she can be 
referred to counselling services; or she can be referred to regular face-to-face CBT 
from a CBT therapist in the team. 
 
It is also possible for a person to be referred directly to either a CBT therapist within 
the IAPT or a counsellor when the referral is first received (i.e. without seeing a case 
manager). The decision is made by the service Duty Manager, a role that is shared 
between staff including CBT therapists and the lead counsellor. This appears to be 
relatively uncommon: with a monthly flow of referrals of around 320 people over the 
period covered by this report, around 19 people per month12 are referred directly to 
the Doncaster PCT counselling service; referrals direct to CBT are very unusual.  
 
Direct referrals to Doncaster’s other counselling service, AB Counselling, or to 
secondary mental health services, are also possible but rare – around one person 
per month for the former and 1 person every two months for the latter13. 
                                                   
12 This is the average over the last three months covered by this report, July-September 2007. 
13 These are averages taken from July-September 2007. 
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THE PROGRESS OF PATIENTS 
 
The Doncaster IAPT has managed an impressively high number of patients. In the 
13 months up to end September 2007, 4,451 patients have been referred to the 
programme. 
 
 
Figure 1: Graph of monthly referrals 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Of all patients referred, 378 were deemed unsuitable14. Reasons are not recorded in 
the database. For some the decision is made early in contact with the service – 
when first referred but before a first session (77 of the 378). Others had an initial 
session (171/378) or multiple sessions (130/378) before the decision was made. 
 
At the end of September 2007, 967 are still in the system, either in treatment or 
waiting for it. 
 
Of those considered suitable for the service who are no longer in the system, 877 
had no sessions. Of these, 42% were coded as ‘discontinued unexpectedly’; these 
are people who did not contact the service after referral and could not be reached by 
the service. Reasons for this are not recorded in the database but could include 
patient characteristics or patients’ views of the service. 27% refused IAPT treatment. 
The remaining 31% are mutually agreed between the service and the patient. 
 
                                                   
14 Their severity scores (on PHQ9 and GAD7) compared with the total of referrals show the 
‘unsuitable’ group have more severe symptoms, with higher proportions scoring 20+ on the PHQ-9 
and 15+ on the GAD-7). 
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This leaves 2,225 who attended one or more sessions, but are no longer in the 
system – we can call them ‘concluded’ patients. Of these 89% were found at 
assessment to be clinical cases (i.e. met the criteria of a score of 8 or more on the 
GAD-7 and/or a score of 10 or more on the PHQ-9 at the initial meeting with the 
IAPT service). 
 
571 of the 2,225 came only once. Again, they can be split into types of service 
conclusion. For 44%, the decision was jointly reached between the service and the 
patient themselves that no further treatment from IAPT was required. 22% of patients 
decided, independently of the service, to refuse further treatment. Finally, 34% were 
coded as ‘discontinued unexpectedly’; these are people who did not contact the 
service again after the first session and could not be reached by the service. 
 
There are significant differences in problem severity between those who attend two 
or more sessions and those who for various reasons attend only one session15. 
Those who finish after one session by mutual agreement with the service, or by 
refusing further treatment, have relatively milder problem severity. Those people with 
whom the service loses contact after one session have relatively more severe 
problem severity, similar to those who stay for two or more sessions. Table 1 gives 
details. 16 
 
 
Table 1: initial scores for those who have only one session versus those who attend 
two or more sessions 
 
Type of completion Initial PHQ-9 value Initial GAD-7 value 
Mean N SD Mean N SD 
Concluded after 2+ 
sessions 
15.8 165
4 
6.2 13.9 165
4 
5.2 
Concluded after 1 
session – by mutual 
agreement 
13.9*, ** 246 7.5 12.4*, ** 246 6.3 
Concluded after 1 
session – patient 
refuses further 
treatment 
14.2** 121 7.3 12.1*, ** 121 6.3 
Concluded after 1 
session – patient drops 
out without contact 
16.6 196 5.5 14.2 196 4.9 
Total 15.5 221
7 
6.4 13.6 221
7 
5.4 
 
* significantly different from concluders with 2+ sessions at the 5% level. 
** significantly different from concluders who drop out without contact after 1 session at the 5% level. 
                                                   
15 Onaway ANOVA for PHQ-9: F=9.744, p<0.0005. One-way ANOVA for GAD-7: F=9.612, p<0.0005. 
16 Significance tests detailed in the table come from ANOVA post-hoc tests (Games-Howell, as 
sample sizes vary substantially across cells and variances are non-homogeneous). 
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Figure 2: Patient progress: Doncaster 
 
 
This leaves 1,654 who had at least 2 sessions. Our analysis focuses on this group; 
since psychological well-being is monitored at each session, these patients have 
multiple PHQ-9 and/or GAD-7 scores, allowing analysis of treatment outcomes. 
 
This group of 1,654 is just over half of all those who were referred to the system, 
found suitable, and are no longer in the system. Virtually all of these patients have 
provided PHQ-9 and GAD-7 scores at pre-treatment and post-treatment. Less 
complete data are available on the prior duration of their problem (77% 
completeness). 
 
On average these patients had 4.9 sessions, comprising a total of around 2.6 hours 
of contact (including the initial session). The median time between sessions is 12 
days. The median length of treatment from first session to last is 8 weeks (the mean 
length is 11 weeks). 
 
Among the 1,654, the most common type of treatment ending was completion of 
treatment by mutual agreement with the service (72%). 21% dropped out without 
contacting the service; 7% actively refused further treatment. 
 
4,451 referred to the 
service 
3,102 ‘concluded’ system 
1,654 attended at least 2 sessions 
967 still in system 
4 status unknown 
877 had no sessions 
571 had 1 session 
1,270 had the prior duration of their 
primary condition coded. Of these, 837 
(66%) had been ill over 6 months. 
833 known to have 
been ill over 6 months 
and have pre- and post-
treatment PHQ-9 and/or 
GAD-7 records 
4,073 were suitable for 
the service 
378 unsuitable 
1,648 have pre- and 
post-treatment PHQ9 
and/or GAD7 records 
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Only 44 of the 1,654 (i.e. 2.7%) received any sessions of step 3 CBT from a 
specialist therapist17. Among those who did, the mean number of CBT sessions was 
5.7 (median 5.0). 
 
The most common activity was guided self-help, using workbooks, which was done 
by 1,442 people (of the 1654). 99 people did some computerised CBT. 355 people 
had at least one session at which none of the above took place – other common 
activities included providing information, medication support, and signposting to 
other services. Group activities are not used at step 2. The CBT therapists do use 
some group work. 
  
Of the 1603 that had any of the step 2 interventions, 34 also had step 3 CBT, while 
1569 did not. This gives a step-up rate of 2.1%.  
 
A more precise measure of step-up takes those who were cases at their last step 2 
session and asks what proportion went on to step 3 CBT. On this basis, the step-up 
rate is 3.8% (25 people of 650), which is surprisingly low. 
 
NICE recommendations for the stepped care management of depression indicate 
that patients who fail to respond at step 2 care should be offered a move to step 3 
where “CBT is the psychological treatment of choice” but therapists could also 
“consider interpersonal psychotherapy (IPT) if the patient expresses a preference for 
it or you think the patient may benefit from it”. (Interpersonal therapy was not 
available in Doncaster IAPT). 
 
Of the 625 who did not ‘step up’ on the more precise measure, 54% completed 
treatment in agreement with the service, 35% dropped out of treatment, and 11% 
refused further treatment.  
 
Of the 25 who did ‘step up’ on the more precise measure, 67% completed treatment 
in agreement with the service, 21% dropped out of treatment, and 13% refused 
further treatment. 
 
One aspect of the IAPT service that is not captured in the administrative database on 
which this report is based is referrals onward from IAPT to counselling and to other 
mental health services. People can be referred for counselling if they meet one or 
more of the following criteria: 
1. “They are experiencing mild, moderate or severe anxiety or depression. 
2. They have been assessed by a case manager as potentially unsuitable for 
low-intensity CBT involving the depression recovery or anxiety self-help 
programmes, or computerised CBT. 
3. They have opted for counselling following a sufficient period of low intensity-
CBT with no symptomatic response. 
4. They have identified through case management unresolved issues that are 
impacting on their current coping methods and personal development. 
5. Their referral after assessment following initial contact and discussion with the 
duty manager is deemed unsuitable due to the following: 
                                                   
17 The rate is higher if one includes in the calculation patients still in treatment. Including all patients 
who have completed treatment or are still in treatment, and who have had at least one session, 4.1% 
have received one or more sessions of step 3 CBT (126 people of 3041). 
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a. identification of issues that are historic or have a developmental nature 
that are impacting on current life difficulties 
b. relationship difficulties 
c. problems with adjustment (eg to parenthood, retirement, diagnosis of 
illness) 
d. low focus and low motivation towards implementing changes 
e. a prolonged or complex grief reaction or other high level of emotional 
distress 
f. a high requirement for risk management 
g. a complex history, with significant risk and/or high impairment of 
functioning 
h. a number of previous interventions with unhelpful outcomes.”18 
 
The IAPT service has done some analysis of referral patterns, which we draw on 
here. Using data from July to September 2007, the average referral rate from case 
managers to the Doncaster PCT counselling service is around 37 people per 
month19. This is generally considered a form of ‘stepping up’ by the Doncaster IAPT 
as most of the counselling service activity is classified as high intensity treatment, 
while the case management service is low intensity. In addition, as mentioned earlier 
around 19 patients per month are referred directly to the service without being seen 
by a case manager first. 
 
Patients can also be referred to AB Counselling who provide services for Doncaster 
PCT in east and central Doncaster; the rate here is about 10 per month (around 90% 
occurring after having seen a case manager). A small number of patients are 
referred to the secondary mental health services provided by RDaSH (around 5 per 
month, 85% after having seen a case manager). 
 
As the IAPT database does not code onward referrals, it is not possible to cross-
reference these numbers with the data that shows the type of treatment ending a 
person had or by the number of sessions a person had with a case manager. The 
Doncaster PCT counselling service does keep paper-only outcome measures (such 
as the PHQ-9, GAD-7 and CORE-OM measures) and an ACCESS database 
tracking, for example, numbers referred to the counselling service, and the IAPT is 
currently auditing this information. 
 
 
 
 
 
                                                   
18 Quoted from White (2008). 
19 The rate was lower in the first few months of the IAPT, so that the total over the period of this report 
is around 420. 
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PSYCHOLOGICAL OUTCOMES 
 
The data on the psychological states of patients are based on verbal answers by 
patients entered onto the computer by the case manager at the start of each 
session. 
 
If we focus on whether a person has recovered or not, we can describe as ill 
someone who has a score of 8 or more on the GAD-7 and/or a score of 10 or more 
on the PHQ-9. Such a person is a ‘case’. On this definition 1494 of the 1,648 for 
whom we have pre- and post-treatment scores were ill at the beginning of their first 
session. Of these 56% had recovered by the time they left the system. 
 
Alternatively we can look at the change in the average score on each questionnaire, 
shown in Table 2. We can calculate effect sizes from these by dividing the mean 
difference of each pair of pre- and post-treatment scores by the pooled standard 
deviation of this mean difference. The effect sizes are 1.16 on the PHQ-9, 1.12 on 
the GAD-7, and 0.93 on the CORE-OM. 
 
 
Table 2: pre- and post-treatment scores for all 
 
  Pre Post 
PHQ-9 Mean (SD) 
 
N 
15.8 (6.2) 
 
1653 
7.5 (6.9) 
 
1653 
GAD-7 Mean (SD) 
 
N 
13.9 (5.1) 
 
1651 
6.8 (6.2) 
 
1651 
CORE-
OM 
Mean (SD) 
 
N 
1.88 (0.59) 
 
92 
1.18 (0.82) 
 
92 
 
The change in scores from pre- to post-treatment is significant for all measures.20 
 
 
Outcomes by duration 
 
Table 3 shows recovery rates split by the prior duration of illness. Table 4 shows pre- 
and post-treatment scores split by prior duration. 
 
The differences in recovery rates between the duration categories in Table 3 are 
significant21, with lower recovery rates being observed for more chronic cases. 
 
                                                   
20 For PHQ-9 F= 2217.500, p <0.0005; for GAD-7 F= 2062.002, p<0.0005; for CORE-OM F=78.852, 
p<0.0005. 
21 Chi-square=13.103, p=0.022. Analysis included only those with prior duration of illness recorded. 
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Table 3: recovery rates, by duration 
 
Prior problem duration % recovery N. of cases 
Under 3 months 60 202 
3-6 months 63 187 
6 months – 1 year 54 211 
1-2 years 54 181 
2-4 years 53 151 
4+ years 47 218 
Missing duration data 59 344 
Total 56 1494 
 
Note: this table includes only patients who are clinical cases, i.e. met the criteria of 
scoring 8 or more on the GAD-7 and/or 10 or more on the PHQ-9 at the initial 
meeting with the IAPT service.  
 
 
Table 4: pre- and post-treatment scores, by duration 
 
  PHQ-9 GAD-7 CORE-OM 
Problem 
duration 
 Pre Post Pre Post Pre Post 
Under 3 months 
 14% 
Mean 
(SD) 
 
N 
15.6 
(6.3)
226
7.1 
(6.8)
226
13.7 
(5.00)
226
6.2 
(6.0)
226
1.74 
(0.36) 
 
8 
1.03 
(0.98) 
 
8 
3-6 months 
 12% 
Mean 
(SD) 
 
N 
16.2 
(6.2)
205
6.8 
(6.8)
205
13.6 
(5.2)
205
6.0 
(5.6)
205
1.96 
(0.50) 
 
14 
1.08 
(0.61) 
 
14 
6 months – 1 year 
 15% 
Mean 
(SD) 
 
N 
15.7 
(6.3)
240
7.3 
(6.7)
240
13.6 
(5.1)
240
6.6 
(5.8)
240
1.78 
(0.66) 
 
15 
1.43 
(0.79) 
 
15 
1-2 years 
 12% 
Mean 
(SD) 
 
N 
15.6 
(6.3)
195
7.3 
(6.6)
195
14.1
(5.1)
195
7.0 
(6.2)
195
2.09 
(0.31) 
 
12 
1.32 
(0.89) 
 
12 
2-4 years 
 10% 
Mean 
(SD) 
 
N 
15.9 
(5.9)
162
7.5 
(6.6)
162
14.1 
(5.1)
162
7.3 
(6.3)
162
1.94 
(0.54) 
 
11 
1.28 
(0.81) 
 
11 
4 years + 
 14% 
Mean 
(SD) 
 
N 
16.4 
(5.9)
236
8.9 
(7.7)
236
14.5 
(5.0)
236
8.1 
(6.9)
236
1.80 
(0.79) 
 
18 
1.11 
(0.95) 
 
18 
  19
Missing duration 
data 
23% 
Mean 
(SD) 
 
N 
15.3 
(6.2)
384
7.5 
(7.1)
384
13.5 
(5.3)
384
6.5 
(6.1)
384
1.87 
(0.66) 
 
14 
1.01 
(0.80) 
 
14 
Total Mean 
(SD) 
 
N 
15.8
(6.2)
1648
7.5
(6.9)
1648
13.8
(5.1)
1648
6.8
(6.2)
1648
1.88 
(0.59) 
 
92 
1.18 
(0.82) 
 
92 
 
The changes in scores over time (from pre- to post-treatment) are significant for all 
measures in Table 4.22 The interaction effects between time and duration are not 
significant for any of the measures.23 
 
The IAPT Programme Board recommended that the Doncaster and Newham 
demonstration sites should not treat patients whose problem duration was less than 
six months24. This was recommended to assist the evaluation of outcomes. While 
NICE guidelines do not generally link treatment to prior duration of condition25, it is 
the case that natural recovery is common in recent onset cases of anxiety and 
depression in primary care and so must be taken into account when evaluating to 
what extent any improvements would have happened anyway, and to what extent 
they can be attributed to the treatment. In the absence of a randomised control group 
(waitlist or treatment as usual) results need to be ‘benchmarked’ against standard 
data on recovery rates and benchmarking is difficult for recent onset cases26. 
 
Doncaster chose not to follow the recommendation for a range of reasons: it was 
believed that early intervention was appropriate as a preventative measure; and the 
service wished to be responsive to patient demand as part of the patient choice 
agenda. As of end September 2007, 34% of patients had their condition for less than 
6 months at the start of treatment (i.e. 433 out of the 1270 with duration coded, 
treatment concluded and attended 2 or more sessions). We will consider these 
individuals separately, after considering first the remaining 66% whose problem 
duration was greater than six months at the start of treatment.  
 
 
Long-term cases 
 
The literature suggests that natural recovery is modest in patients where the problem 
duration is more than 6 months. Such individuals have tended to report low recovery 
rates when placed on wait-lists or placebo medication. If we look at wait-list control 
                                                   
22 GLM Repeated Measures. PHQ-9 F=1707.032, p<0.0005; GAD-7 F=1508.851, p<0.0005; CORE-
OM F=54.673, p<0.0005. Analysis included only those with prior duration of illness recorded. 
23 There is a main effect for duration categories on the GAD-7 measure only; F=3.328; p=0.005. 
24 Unless problem duration was at least 3 months and the person faced substantial risk to 
accommodation, employment or associated physical health due to their mental health condition. 
25 There are some exceptions, such as in guidelines for PTSD, or the suggestion of 2 weeks ‘watchful 
waiting’ by GPs for recent onset depression. 
26 While a randomised controlled trial can pick up relatively small intervention effects, one needs 
substantial differences in recovery rates between a benchmark and the observed result to conclude 
there has been clinical benefit. If the difference is small or within the range of the benchmark results, 
one cannot be confident that the intervention has worked, even though it is possible that a 
randomised controlled trial could have found a modest intervention effect. 
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comparisons, Posternak and Miller’s (2001) meta-analysis of wait-list control groups 
reports an average recovery rate from depression of approximately 20%, and a 
percentage change on the Beck Depression Inventory of approximately 16%. If one 
looks at wait list controls in randomised controlled trials of CBT for anxiety disorders 
that have focussed exclusively on patients with a duration of more than 6 months, 
recovery rates rarely exceed 5% in the wait-list. 
 
The Doncaster recovery rates and symptom change data for the 66% of patients 
who had problem duration of greater than 6 months comfortably exceed the existing 
benchmarks. In Doncaster, 52% of patients who met caseness criteria on the PHQ-9 
and/or the GAD-7 at pre-treatment no longer met caseness criteria at post-treatment 
and the effect sizes are 1.22 on the PHQ-9 and 1.13 on the GAD-7. It therefore 
seems reasonable to conclude that the treatment offered in the IAPT demonstration 
site is frequently effective in these cases.  
 
Among these patients those who recovered had received significantly more sessions 
(5.8) than those who did not (4.6), and significantly more case manager/therapist 
time (3.0 hours) than those who did not (2.6 hours)27. There was no significant 
difference in recovery rates between the 59% of patients who were taking medication 
(as well as receiving the IAPT psychological interventions) and those who were not 
taking medication (both have recovery rates of 52%)28. 
 
 
Recent onset cases 
 
We turn now to the 34% of patients who had before treatment had their problem for 
less than 6 months. Several studies have looked at recovery rates in recent onset 
cases of depression and anxiety in primary care that were ‘treated as usual’ in 
primary care (TAU). For the present purposes the four studies that are most 
obviously relevant are Catalan et al (1984), Spijker et al (2002), Tennant et al (1981) 
and Kendrick et al (2006). 
 
The Catalan et al (1984) paper focuses on recent onset cases of depression and/or 
anxiety in primary care, with caseness defined by general health questionnaire 
(GHQ) thresholds. None of the TAU patients had received psychological 
interventions from trained individuals, yet 60% of cases had recovered within 1 
month and 70% had recovered within 6 months. 
 
The Spijker et al (2002) study is an investigation of the duration of new episodes of 
major depression in the community. 50% of cases recovered within 3 months, and 
63% within 6 months. These results are broadly similar to those reported in Tennant 
et al’s (1981) earlier community study which found that recent onset (less than 6 
months) cases of anxiety and/or depression had a 68% recovery rate after 4 weeks. 
 
The Kendrick et al (2006) study is a controlled trial of recent onset cases of 
depression and/or anxiety (prior duration being between 1 and 6 months). Caseness 
was defined using GHQ thresholds. Patients were allocated randomly into 3 groups: 
                                                   
27 Figures include initial session. 
28 These calculations exclude those whose medication status is unknown (14% of the group).  
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either treatment as usual by GPs, or community mental health nurses providing 
generic care, or community mental health nurses providing NICE-guidance-
advocated problem-solving treatment. In the treatment as usual condition GPs were 
not allowed to refer patients for psychological therapy during the first 8 weeks of the 
study. The overall results showed that all three groups showed marked 
improvements but did not differ from each other. For the treatment as usual GP care 
group, the pre-treatment to 8 weeks uncontrolled effect sizes are 2.04 for the GHQ 
and 1.18 for the hospital anxiety and depression scale (HADS) (average of the effect 
sizes for depression and anxiety scales). 
 
The Doncaster IAPT cases with an initial duration of less than 6 months show 
recovery rates and effect sizes similar to those observed in the GP care alone 
conditions in Catalan et al (1984) and Kendrick et al (2006), as well as to the 
community recovery rates for recent onset depression in the Spijker et al (2002) and 
Tennant et al (1981) studies. Some 62% of the Doncaster patients who were 
classified as cases on the PHQ-9 and/or GAD-7 at pre-treatment were classified as 
non-cases at post-treatment, and the pre-treatment to post-treatment effect size on 
the PHQ-9 was 1.33 (the effect size on the GAD-7 was 1.30). 
 
Benchmarking is, of course, a very rough way of establishing clinical effectiveness. 
However, with that caveat, it seems we cannot exclude the possibility that the IAPT 
treatment that was provided for the cases with the duration of less than 6 months 
was no more effective than what would have happened if the treatment was not 
being provided. Of course, it is important to realise that this is a statement about 
what conclusions can, and cannot, be rejected. The overlapping results of the IAPT 
demonstration site with the benchmarking studies do not demonstrate that the IAPT 
treatment was ineffective. A randomised controlled trial showing equivalence would 
be needed for such a conclusion.  
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EMPLOYMENT AND BENEFIT OUTCOMES 
 
In analysing impacts on employment we focus on people who have concluded their 
treatment and had 2 or more sessions. We have 445 such patients for whom pre- 
and post- data on employment exist. 
 
One would not expect major changes in employment status during a short course of 
treatment. However a significant number of patients who were originally off work and 
on Statutory Sick Pay (SSP) returned to work. This is shown in table 5. The net 
increase of people at work (and not on SSP) corresponded to 4% of the treated 
population. This matches the assumption in the Comprehensive Spending Review 
cost-benefit analysis by Layard et al (2007) that treatment raises the employment 
rate of those treated by 4 percentage points over the following 2 years. There was a 
small net increase in people on benefit; such increases in benefit are likely when 
people have recently become ill, given the time that it takes to get onto benefit. 
 
Similar results apply if focus is on long-term cases; indeed the net increase in 
numbers in employment is higher (5%) due to shifts both from SSP receipt and from 
the ‘other’ category. See Table 6 for details.  
 
Results for the recent-onset people are given in Table 7. 
 
Incomplete employment questionnaires mean it is not possible to look at changes in 
sick days among the employed. 
 
 
Table 5: Changes in employment for all 
 
 Pre-treatment 
Benefit 
recipient 
(IB, IS, 
JSA)
Receiving 
Statutory 
Sick Pay
Employed 
(no SSP)
Other Total
Post-
treatment 
Benefit 
recipient 
(IB, IS, 
JSA) 
115 6 8 15 144
Receiving 
Statutory 
Sick Pay 
3 27 13 0 43
Employed 
(no SSP) 
9 27 149 7 192
Other 14 3 5 44 66
Total 141 63 175 66 445
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Table 6: Changes in employment for patients with over 6 months prior problem 
duration 
 
 Pre-treatment 
Benefit 
recipient 
(IB, IS, 
JSA)
Receiving 
Statutory 
Sick Pay
Employed 
(no SSP)
Other Total
Post-
treatment 
Benefit 
recipient 
(IB, IS, 
JSA) 
80 1 3 9 93
Receiving 
Statutory 
Sick Pay 
2 14 4 0 20
Employed 
(no SSP) 
7 14 81 0 102
Other 4 0 1 22 27
Total 93 29 89 31 242
 
 
Table 7: Changes in employment for patients with less than 6 months prior problem 
duration 
 
 Pre-treatment 
Benefit 
recipient 
(IB, IS, 
JSA)
Receiving 
Statutory 
Sick Pay
Employed 
(no SSP)
Other Total
Post-
treatment 
Benefit 
recipient 
(IB, IS, 
JSA) 
17 3 2 4 26
Receiving 
Statutory 
Sick Pay 
1 9 6 0 16
Employed 
(no SSP) 
1 10 38 4 53
Other 8 2 2 12 24
Total 27 24 48 20 119
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FOLLOW-UP SURVEY 
 
To fully evaluate the outcomes of the service it is important to determine if the 
psychological and employment gains achieved at the end of treatment are largely 
maintained over time. As the Doncaster (and Newham) IAPT services stop collecting 
any information on patients once they have their last treatment session, a one-off 
follow-up survey was carried out. 
 
Patients who had completed treatment by 1 September 2007, with at least two 
treatment sessions, were eligible for the follow-up survey. The intention was to 
include all who had completed treatment at least three months previously. 
 
Delays in implementing the survey meant in practice it included all who had 
completed treatment at least four months previously. The average amount of time 
between last treatment session and the follow-up survey, for the eligible group, was 
42 weeks.29   
 
The eligible group totalled 1444 people. Doncaster took a random sample of 893 
people from this group30. Of the 893 surveyed, 452 people responded (51%). 
Respondents had significantly lower final PHQ-9 score than the sample group31.  
 
The follow-up survey consisted of three questionnaires – the PHQ-9, the GAD-7, and 
an employment status questionnaire (the same as used during treatment). People 
were mailed the questionnaires, for self-completion; those who did not return them 
were then phoned and offered the chance to complete them over the phone. 
 
Tables 8 and 9 show the psychological outcomes and Tables 10 and 11 the 
employment outcomes for, respectively, all respondents and those whose problem 
duration at start of treatment was six months or over32. 
 
The changes in average PHQ-9 and GAD-7 scores over time are significant. At 
follow-up patients continue to have significantly lower PHQ and GAD scores than at 
pre-treatment33. In addition, there is a modest, but significant increase in PHQ & 
GAD scores from post-treatment to follow-up.34 The results for those with over six 
months prior problem duration mirror those of the whole group.35 
 
 
                                                   
29 The shortest amount of time was 16 weeks; the longest 72 weeks. 
30 The sub-sample is representative of the full eligible group in terms of initial and final PHQ-9 and 
GAD-7 scores, and in terms of the prior duration of the current condition (no significant differences). 
The sub-sample has a longer time from last treatment session to the follow-up survey than the full 
eligible group (the mean difference was 24 days, t=7.711, p<0.0005). 
31 The mean difference in PHQ-9 scores was -0.657, t=-2.033, p=0.043. 
32 See the section on psychological outcomes for discussion of the relationship between problem 
duration and outcomes. 
33 For PHQ-9, the change from pre-treatment to follow-up: F=342.194, p<0.0005. For GAD-7, the 
change from pre-treatment to follow-up: F=310.809, p<0.0005. 
34 For PHQ-9, the change from post-treatment to follow-up: F=12.566, p<0.0005. For GAD-7, the 
change from post-treatment to follow-up: F=6.219, p=0.013. 
35 From pre-treatment to follow-up: PHQ-9 - F=107.833, p<0.0005; GAD-7 - F=102.898, p<0.0005. 
From post-treatment to follow-up: PHQ-9 - F=10.769, p=0.001; GAD-7 - F=5.628, p=0.019. 
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Table 8: Psychological outcomes for all follow-up survey respondents 
 
  Pre Post Follow-up 
Recovery 
rate 
% 
 
N 
 56% 
 
452 
50% 
 
446 
PHQ-9 Mean (SD) 
 
N 
15.7 (6.3) 
 
435 
7.4 (6.9) 
 
435 
8.7 (7.7) 
 
435 
GAD-7 Mean (SD) 
 
N 
13.5 (5.4) 
 
437 
6.8 (6.4) 
 
437 
7.6 (6.8) 
 
437 
 
 
Table 9: Psychological outcomes for follow-up survey respondents with 6 months or 
more prior problem duration 
 
  Pre Post Follow-up 
Recovery 
rate 
% 
 
N 
 47% 
 
202 
40% 
 
199 
PHQ-9 Mean (SD) 
 
N 
15.4 (6.3) 
 
217 
8.2 (7.0) 
 
217 
10.0 (8.0) 
 
217 
GAD-7 Mean (SD) 
 
N 
13.9 (5.3) 
 
220 
7.9 (6.5) 
 
220 
9.0 (7.0) 
 
220 
 
 
Table 10: Changes in employment for all follow-up survey respondents 
 
 Pre-treatment 
Benefit 
recipient 
(IB, IS, 
JSA)
Receiving 
Statutory 
Sick Pay
Employed 
(no SSP)
Other Total
Follow-up Benefit 
recipient 
(IB, IS, 
JSA) 
72 13 7 16 108
Receiving 
Statutory 
Sick Pay 
4 2 11 0 17
Employed 
(no SSP) 
17 31 132 10 190
Other 5 2 5 16 28
Total 98 48 155 42 343
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Among the full group of respondents to the follow-up survey, the net increase in 
those employed is 10.2%, partly due to a drop in the numbers receiving Statutory 
Sick Pay of 9.0%. There is a small net increase in benefit receipt of 2.9%. 
 
 
Table 11: Changes in employment for follow-up survey respondents with 6 months or 
more prior problem duration 
 
 Pre-treatment 
Benefit 
recipient 
(IB, IS, 
JSA)
Receiving 
Statutory 
Sick Pay
Employed 
(no SSP)
Other Total
Follow-up Benefit 
recipient 
(IB, IS, 
JSA) 
42 4 5 7 58
Receiving 
Statutory 
Sick Pay 
3 2 8 0 13
Employed 
(no SSP) 
8 7 64 3 82
Other 1 1 4 8 14
Total 54 14 81 18 167
 
Among those whose problems had existed for at least 6 months prior to treatment 
from IAPT, the net increase in employment at follow-up is 0.6%, mirrored by a drop 
in the numbers receiving Statutory Sick Pay of 0.6%. There is a net increase in 
benefit receipt of 2.4%. 
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FUNDING 
 
The Doncaster IAPT spent £1,584K from inception to 30 September 200736:  
 
 Actuals: 
Inception to Sept 07 
(~14 months) 
Budgeted:  
07/08 financial year 
(12 months) 
 Spend 
(£000)
Average 
FTE*
Budget 
(£000) 
FTE  
Pay   
Directors 117 1.1 110 1.5 
Team manager 51 1 36 1 
Lead counsellor 17 0.5 21 0.5 
CBT therapists 143 2.3 202 4.0 
Case managers** 527 19.3 449 20.5 
Administrators 71 4 86 4 
   Pay total 926 904  
Non-Pay   
Training 270 155  
Facilities 178 155  
IT 117 91  
Advertising 10 15  
Other 83 111  
   Non-pay total 658 526  
Total cost of therapy 1,584 1,430  
 
* Note: estimated - precise staffing levels have varied over the period. 
** These figures include funding for 6 case manager jobs filled by those employed in 2005 as 
graduate mental health workers 
 
One should note that a proportion of the training costs of £270K should not properly 
be included in the running cost of the IAPT service. 
 
 
                                                   
36 The demonstration site went live mid-August 2006. The ‘Actuals’ column shows money spent over 
the 14 months from August 06 to September 07. 
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PUTTING THE SERVICE IN CONTEXT 
 
Finally, it is helpful to put this service in context. The population of Doncaster is 
290,000, including 233,000 adults.37 From analysis of GP records covering 40,000 
adults, we find that in January – June 2007 5.5% of adults visited the GP with “a new 
record of depressive symptoms or other mental health problems” as diagnosed by 
the GP (Chan et al., 2008). This suggests an annual rate of new diagnoses of 11% - 
or 25,630 adults in the whole of Doncaster.38 
 
Of these, “new depressive symptoms” accounted for 60% of diagnoses. 
 
These figures of GP diagnoses are clearly much larger than the number of 4,451 
patients referred to IAPT over a 14- month39 period. However if we were to focus on 
cases where the patient had symptoms for over six months, we would find a higher 
proportion going to IAPT (though a specific calculation is not possible). 
 
In fact the scale at which IAPT has operated has been extremely impressive, given 
the short time it has had to operate. The effectiveness of treatment has also been 
impressive.   
 
The main questions still to be understood are: why so few patients with a primary 
diagnosis of anxiety disorders other than GAD were referred to the service, and why 
so few patients were thought to need Step 3 care. 
                                                   
37 Latest available ONS mid-year estimate, for 2005. 
38 This compares with 8.3% in national data collected in 1991 for people aged 16-64 for people 
presenting with any new or ongoing mental health problem (National Mental Health Statistics). It also 
compares with 17% of the national adult population diagnosed as mentally ill in the Psychiatric 
Morbidity Survey of a representative sample of households in 2004. 
39 14 months is the approximate period covered by this report – from August 2006 to end September 
2007. 
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2. NEWHAM 
 
ORGANISATION 
 
Prior to the IAPT demonstration site, Newham already had a relatively developed 
structure for delivering psychological therapy services, organised in three tiers: 
• Tier 1: GP-practice-based, brief-therapy service, run by the Newham Primary 
Care Trust (PCT). 
• Tier 2: Borough-wide individual, group and family therapy (including 
psychodynamic, systemic and CBT therapy), run by the PCT. 
• Tier 3: Borough-wide secondary-care specialists, run by the East London and the 
City Mental Health Trust. 
 
The Newham demonstration site consists of a cognitive behavioural therapy (CBT) 
service created from scratch in mid-2006 plus a linked employment service40. It 
started in a somewhat difficult environment involving some scepticism by existing 
services, which made it difficult initially to obtain referrals. 
 
The CBT service now delivers three steps of intervention: 
• Step 2a: computerised CBT, guided self-help, group psychoeducation 
• Step 2b: brief CBT (individual and group) 
• Step 3: full CBT (individual and group). 
Generally, step 2a is delivered by assistant therapists, Steps 2b and 3 by CBT 
therapists. The service considers step 2a ‘low intensity’ and 2b and 3 as ‘high 
intensity’. 
 
The service developed in two phases. In phase one, it was available to 14 GP 
surgeries (covering approximately one-third of the Newham working age population 
or around 50,000 adults), as well as to local residents referred by employers, 
community groups, or Jobcentre Plus. The focus was on delivering steps 2b and 3 
using qualified therapists. 
 
Between January and March 2007, the service entered its phase two. The referral 
base was broadened to include self-referrals from local residents, and to gradually 
incorporate all Newham GP surgeries. The focus also broadened, to include more 
delivery of step 2a services, requiring the recruitment of more assistant therapists. 
 
The associated employment service is provided by Mental Health Matters and 
operates side-by-side with the CBT service. Employment coaches help patients to 
gain employment or resolve employment problems. It should be noted that the 
Pathways to Work programme has not yet been rolled out in Newham. 
 
 
 
 
                                                   
40 IAPT finance also pays for enhancement of the pre-existing Primary Care Trust psychological 
services, funding 1 additional therapist, 2 assistant therapists and associated management, to deliver 
NICE-supported non-CBT therapies (particularly systemic therapy). See the funding section for costs, 
and Annex D for patient data from the enhancement. 
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Referrals 
 
A broad range of common mental health conditions (depression and all the anxiety 
disorders) are covered; only those with very severe conditions – like psychosis – are 
not eligible for the IAPT. People with a severe drug or alcohol problem, which 
precludes them from participating fully in the therapy process, are also excluded.  
 
Referral sources: 
• GP: 75% 
• Other health professional: 4% 
• Self-referral: 21%41 
 
Personal characteristics of those referred: 
• 60% are women 
• 49% are from BME communities (of these, 25% are Asian, 17% are Black). 
• 13% are aged 18-24, 58% are aged 25-44 and 25% are aged 45-64. Numbers 
under 18 and over 65 are very low (2% each). 
• 13% do not speak English42. 
 
Diagnosis. Diagnosis in Newham is through diagnostic assessment43 undertaken by 
the service, based on the ICD10 framework. The primary diagnoses were as follows: 
• 46% depression 
• 43% anxiety disorders: 
o 3% agoraphobia 
o 5% social phobia 
o 1% other specific phobia 
o 6% panic disorder 
o 6% generalized anxiety disorder 
o 4% obsessive compulsive disorder 
o 5% post traumatic stress disorder 
o 3% health anxiety 
o 10% other 
• 12% other disorders (including anger, personality disorder, eating disorders, 
bipolar affective disorder, schizophrenia, and mental and behavioural disorders 
due to psychoactive substance use) 
 
Two-fifths experienced two or more disorders: 
• 60% one disorder 
• 25% two disorders 
• 15% three or more disorders. 
                                                   
41 The relative proportion of self-referrals rose over this time with the successful roll-out of phase two 
and continues to increase. In the last three months covered in this report (July-September 2007), self-
referrals were 42% of all referrals. 
42 The service is able to accommodate many non-English speakers. There is in-house capacity to 
provide services directly in, or have an in-house interpreter available for, Punjabi, Hindi, Bengali and 
Urdu. The services of external interpreters are used where needed and to cover other languages. 
43 Not all patients referred have assessments recorded (N=411, 39% of referrals). Those without 
assessments include those who are still in the service whose assessment has not yet taken place, 
those found unsuitable for the service at initial contact, and those who left the service prior to 
assessment. 
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Grouping all disorders together (primary and secondary), the most common disorder 
was anxiety (45%) followed by depression (42%). 
 
From the diagnostic information, it would appear that the Newham service covered 
the full range of conditions relevant to the IAPT initiative.  
 
Severity. The presenting level of morbidity at assessment (using the PHQ-9 and 
GAD-7 scores recorded at first session) were: 
• PHQ-9: 
o 7% score 0-4 
o 17% score 5-9 
o 23% score 10-14 
o 26% score 15-19 
o 28% score 20+ 
• GAD-7: 
o 9% score 0-4 
o 18% score 5-9 
o 29% score 10-15 
o 44% score 15+ 
 
Patients are considered to be a clinical ‘case’ if they score above a certain level on 
the PHQ-9, or the GAD-7, or on both. For the PHQ-9, a score of 10 or over indicates 
clinical caseness; for the GAD-7, recent research indicates a score of 8 or over 
indicates clinical caseness (Kroenke et al, 2002; 2007). On this basis, 86% of the 
referred individuals are clinical cases. 
 
Duration. 78% of those referred have had the current episode of illness of 6 months 
or over.44 
 
The median duration of current episode is 3.3 years and the mean is 7.0 years45. 
The mean duration is somewhat skewed by a group with very long durations; just 
under half had durations over 4 years: 
• 22% had this episode for less than 6 months 
• 17% had this episode for between 6 months and 2 years 
• 61% had this episode for over two years. 
 
Entry to the service is restricted by previous duration of the patient’s condition: either 
the condition must have been in place for six months or more; or for three months 
together with substantial negative impact on accommodation, employment or 
associated physical health. 
 
                                                   
44 This is of the 59% of referrals who have duration recorded. The PHQ9 scores of those with 
durations under 6 months is slightly more spread out than the total of referrals, with more in the ‘mild’ 
and the ‘moderate-severe’ groups. On the GAD7 they showed proportionately more with clinically 
significant scores (8 and above), especially in the ‘moderate’ group. 
45 This duration recording is intended to capture the length thus far of the current episode of illness. 
However, data inspection suggests that in some cases the recording may reflect total lifetime history 
of illness, with the furthest outlier being a duration of 50 years. There is also a separate record kept of 
duration since first ever onset of the illness (mean is 5.8 years). 
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Since service entry is restricted by prior duration of condition, not all those referred 
with a prior duration of less than six months will be accepted – the proportion of 
those with prior duration under six months among those accepted for treatment is 
21%, versus 28% for those the service did not accept. 
 
Self-referral. Newham encouraged self-referral as an experiment to see if this route 
into the service facilitates access for groups who are not well served by GP referral 
alone. When self-referral cases are compared with those from the GP they did not 
differ in initial severity of the condition (PHQ-9 / GAD-7)46. They did have a longer 
prior duration of condition (7.5 years mean versus 6.9; medians are 4.0 years versus 
3.0), but the difference was not significant. 
 
There were some differences in the ethnicity of self-referral cases compared to those 
referred by a GP. Table 12 shows the ethnic distribution across the two referral 
sources and compares it with the ethnic distribution of GP-detected mental health 
conditions in Newham (Chan et al, 2008). While the overall pattern of ethnic 
distribution does not differ significantly between the two referral sources, if one 
compares simply the odds of a GP-referral patient being Black / Black British to the 
odds of this for a self-referral patient, the difference is significant at the 5% level.47  
 
 
Table 12: Patient ethnicity by referral source 
 
Ethnic group GP referral Self-referral GP 
detection 
N % N % % 
White 357 52 96 47 41 
Asian / Asian British 178 26 48 24 28 
Black / Black British 110 16 45 22 25 
Chinese or other 18 3 5 3 2 
Mixed 25 4 9 4 3 
Total 688 100 203 100 100 
 
There are also some differences in the primary diagnoses of those referred by the 
GP versus those self-referring. Table 13 shows these differences. Social phobia and 
obsessive-compulsive disorder were relatively more common among self-referrers 
that among GP referrals.48 
 
 
 
 
                                                   
46 Self-referral cases compared to GP-referral cases also do not differ in final, post-treatment PHQ-9 
or GAD-7 scores.  
47 Chi-square on full ethnic distribution shown in Table 12: Chi-square=4.676; p=0.322. Chi-square on 
proportion of Black / Black British patients: Chi-square=4.165, p=0.041. 
48 The different patterns of diagnoses comparing the two referral sources are significant as a whole; 
Likelihood ratio=38.281, p=0.032. The differences in levels of social phobia and obsessive compulsive 
disorder are individually significant when comparing the odds of a GP-referral patient having one of 
these diagnoses to the odds of this for a self-referral patient; for social phobia t=-4.472, p<0.0005; for 
OCD t=-2.069, p=0.039. 
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Table 13: Patient diagnoses (ICD-10) by referral source 
 
Diagnosis GP referral Self-referral 
N % N % 
Disorder due to psychoactive substance 
use 
5 1 x x 
Depression and recurrent depression 227 47 50 42 
Other mood disorder 9 2 x x 
Agoraphobia 13 3 3 3 
Social phobia 14 3 15 13 
Specific phobia 4 1 3 3 
Other anxiety disorder 32 7 6 5 
Panic disorder 28 6 8 7 
Generalised anxiety disorder 31 6 4 3 
Obsessive Compulsive disorder 16 3 9 8 
Other reaction to severe stress 15 3 x  x 
Post traumatic stress disorder 24 5 5 4 
Somatoform disorder 14 3 4 3 
Eating disorder 8 2 x x 
Specific personality disorder 11 2 x x 
Symptoms of cognition, perception 
emotion and behaviour disorder 
14 3 4 3 
Other* 19 4 5 4 
Total 484 100 120 100 
 
x data suppressed – numbers below threshold of N=3 
* this includes a range of conditions which did not individually meet the N=3 
threshold for either referral group 
 
Medication. We know that 20% of the people referred to the service are receiving 
psychotropic medication when they begin treatment. However it is possible this is an 
underestimate. Until recently the computer system did not allow clinicians to give a 
positive code for no medication. This means one cannot distinguish, from the 
database records, those known not to take medication from those for whom the 
information was not recorded49.  This has since been rectified. 
 
Of those known to be taking psychotropic medication, the types of medication are: 
• 73% SSRI 
• 9% tricyclic 
• 5% sedative 
• 2% mood stabilisers 
• 1% antipsychotic 
• 9% other 
 
 
                                                   
49 11% are recorded as not taking medication; 69% do not have medication information recorded. The 
Newham team state that they enquired about medication (and coded it if it was present) in almost all 
instances, which implies those without a medication record equals those not taking medication. 
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Staff 
Within IAPT: In September 2007 IAPT employed the following numbers (FTE), 
though as we show later, these numbers are higher than the average over the life of 
the project: 
 
Staff type Total FTE: (Which includes 
vacant:) 
Therapy service  
Clinical lead 
- Consultant rate 
1 (0) 
Deputy lead 
- Pay band 8c 
0.4 (0.4) 
‘Senior’ CBT therapists 
- Pay band 8b 
2.8 (0) 
‘Experienced’ CBT therapists 
- Pay band 8a 
2.8 (0) 
CBT therapists 
- Pay band 6 
3.1 (0) 
Honorary CBT therapists50 1.2 (0.4) 
Assistant CBT therapists 
- Pay band 5 
6 (0) 
Project managers 
- Pay band 7 
1 (0) 
Administrative staff 
- Pay bands 3-5 
6.4 (2.7) 
   Therapy service total 24.7 (3.5) 
Employment service  
Employment coach manager 1 (0) 
Employment coaches 2 (0) 
   Employment service total 3 (0) 
 
The staff numbers have expanded as part of the ongoing service expansion in phase 
two. Four of the assistant CBT therapists began in May 2007, and three of the CBT 
therapists began in September 2007, as well as additional administrative staff. 
 
The Newham IAPT has a structured programme of professional training and support, 
including clinical supervision, training in CBT towards BABCP accreditation, and 
continuing professional development. 
 
PCT and Mental Health Trust (external to IAPT): As mentioned earlier, Newham 
has already a relatively developed structure for delivering psychological therapy 
services: 
• Within GP surgeries brief therapy is provided by 5.7 FTE clinical staff including 
3.7 psychotherapy, 1.9 counselling, and 0.1 clinical psychology staff (all funded 
by Newham PCT). Therapy is largely multi-model drawing on psychodynamic, 
systemic and CBT approaches. 
                                                   
50 Honorary CBT therapists are still in training. They typically work 0.2 FTE in exchange for expenses 
and supervision time. 
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• A centralised Psychological Services team provides further services at primary 
care level, with 9.5 FTE clinical staff51 who are all psychologists (all funded by 
Newham PCT). Again, much therapy is multi-model, with staff specialisations 
including CBT, systemic, and psychodynamic approaches. 
• A team offering specialist secondary-care services with 14.5 FTE clinical staff: 
6.5 multimodal/integrative; 3.0 psychodynamic, 1.5 medical psychotherapy, 1.5 
CBT, 1.1 systemic, 0.6 art, and 0.3 community psychology. 
 
 
Treatment 
 
All people referred initially attend an assessment with a qualified therapist or an 
assistant therapist working with the supervision of a qualified therapist. The 
assessment is based on the ICD10 framework and uses PHQ-9 and GAD-7 to gauge 
case severity. In Newham all questionnaires are completed by the patient on paper 
in their own time. 
 
The suggested treatment allocation depends on the condition and its severity. The 
intention was that if low-intensity (step 2a) treatments (including guided self-help) 
could be useful, the patient is started on these. Escalation up the stepped grades of 
treatment occurs if the patient has not improved after 4 hours of step 2a or 8 hours of 
step 2b. If at 20 hours with the service (including all levels of treatment) a patient still 
has not improved they will usually be referred on to secondary care (e.g. the 
community mental health team). Some patients could be allocated directly to step 3 
care within IAPT, for example if low-intensity treatments are known to be ineffective 
(such as for patients suffering post-traumatic stress disorder), or if there is 
substantial risk to self or others. 
 
In practice, staffing limitations meant many step 2 treatments, particularly 2a 
treatments, only began to be delivered during phase two of the service delivery, from 
mid-March 2007. This initially limited the implementation of the treatment allocation 
system outlined above. 
 
There is capacity to deliver specialised services in the form of disorder-specific CBT. 
There is a lead therapist for each disorder (conditions such as panic/phobia, OCD, 
PTSD).  
 
The normal mode of treatment is for a patient referred to the service to be contacted 
within a few days and first seen for assessment about 14 days later52. Assessment 
usually lasts around an hour. It takes place at the Newham Psychological Treatment 
Centre (63%) or at the GP surgery (19%), with 17% on the telephone. 
 
For some, ‘flexible engagement’ occurs before formal assessment. This involves 
discussion between the patient and service staff about their illness and the nature of 
the service. Around 29% of referrals have at least one ‘flexible engagement’ contact 
and 13% have two or more. The average duration of a flexible engagement contact 
is 9 minutes, and it almost always occurs on the telephone (86%). 
                                                   
51 This total includes the 1.0 FTE therapist funded via the IAPT budget. 
52 Median value. 
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Flexible engagement aims to encourage referrals to take up the service. It is 
particularly used by self-referrals (55% of self-referrals as against 22% of GP 
referrals have used it). 
 
Following assessment, the patient is allocated to a treatment. Therapy makes use of 
two workbooks, ‘Overcoming Anxiety: A Five Areas Approach’, and ‘Overcoming 
Depression: A Five Areas Approach’, both by Chris Williams. Computerised CBT is 
also available but interestingly is rarely taken up by patients. 
 
Because of the initial staffing limitations discussed above, the balance between low- 
and high-intensity services has varied over time. For those who had already 
completed treatment and had at least one treatment session (excluding flexible 
engagement and assessment) by end September 2007, around two-thirds (69%) 
experienced only step 3 treatment (full CBT therapy). 14% had only step 2 
treatments (step 2a or 2b), and 11% had both.53 Among those who were still in 
treatment and had at least one treatment session (excluding flexible engagement 
and assessment) by end September 2007, the majority (54%) had only received step 
2 interventions. 16% had only had step 3 treatment, and 12% both.54 
 
Both the CBT and employment services are based at the newly established Newham 
Psychological Treatment Centre55. Service users can choose whether they would 
like therapy and employment services to take place at the Centre, at their GP 
surgery, elsewhere, or over the phone. Excluding flexible engagement and 
assessment, the majority of contacts are done face-to-face (84%; 16% are on the 
phone); of the face-to-face contacts, 68% take place at the Centre, 21% take place 
at the GP surgery, and 11% at other locations.  The average length of a face-to-face 
session is 47 minutes, and of a telephone session is 18 minutes.  
 
 
                                                   
53 The balance had missing or ‘other’ codes on treatment type. 
54 The balance had missing or ‘other’ codes on treatment type. 
55 The Centre expanded to a second physical site in November 2007. 
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THE PROGRESS OF PATIENTS 
 
Because a well-established primary care psychological service already existed in 
Newham, the CBT service had at first some difficulties attracting sufficient numbers 
of referrals. This has improved over time (see Figure 3.) 
 
 
Figure 3: Graph of monthly referrals 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
By end September 2007 the system had recorded 1043 referrals. Of these, 231 were 
found unsuitable56. Of the unsuitables, 30 were not eligible for the service, and 41 
were found to not need the service; other specific reasons for unsuitability are not 
recorded in the database. This decision is usually reached when first referred (70 of 
the 231) or at assessment (137 of the 231). 
 
58 of the suitable referrals went directly to the employment service. This normally 
happens after some contact with the IAPT service - for the service choices to be 
explained – but none of these people participated in any clinical therapy activities.57 
 
                                                   
56 The PHQ9 scores of the unsuitables include more patients at the severe end of the spectrum than 
the total of referrals. Conversely, the GAD7 shows more patients at the none/mild end of the 
spectrum. 
57 As the employment service data is not integrated with the therapy service database, there is limited 
further information on these people. From initial profile information collected, it is clear that this group 
were usually referred via non-GP health professionals (31%) or self-referral (39%). They are 
predominantly male (60%) and most often benefit recipients (28 of the 58; note employment status 
was not recorded for 18 of the 58). The severity of their symptoms is lower than the bulk of referrals, 
with 44% not meeting caseness criteria of scoring 10 or more on the PHQ-9 and/or 8 or more on the 
GAD-7. 
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Of those suitable for the service, 87 had no sessions. Most of these people are 
recorded as failing to engage or dropping out without further contact (90%). Specific 
reasons for this are not recorded in the database but could include patient 
characteristics or patients’ views of the service. A further 8% refused the service; the 
remainder were referred elsewhere. 
 
At the end of September 2007, 385 are still in the system, either in treatment or 
waiting for it. 
 
Focusing on the 282 who have concluded treatment in the system, (i.e. attended one 
or more sessions and are no longer in the system), 90% were found to be cases (i.e. 
scored 8 or over on the GAD-7 and/or 10 or over on the PHQ-9 at the first session 
with the service)58. 
 
33 of the 282 had only one session. Of these, 73% were patients who did not contact 
the service again after the first session and could not be reached by the service. The 
remainder are patients who were referred to other services after the first session, 
and patients who refused further treatment. 
 
It would be interesting to look at whether initial scores differ between those who 
attend only one session, and those who attend two or more. However, this analysis 
is limited by the small number of patients with only one session59. The only 
significant difference is that those who conclude after one session by refusing further 
treatment have lower GAD-7 scores than those who conclude after one session by 
dropping out without further contact with the service60. 
 
 
Table 14: initial scores: only one session versus two or more sessions 
 
Type of completion Initial PHQ-9 value Initial GAD-7 value 
Mean N SD Mean N SD 
Concluded after 2+ sessions 15.1 239 6.2 13.5 238 5.2 
Concluded after 1 session – by 
mutual agreement 
x x x x x x 
Concluded after 1 session – 
patient refuses further 
treatment 
13.8 4 6.0 8.3* 4 2.6 
Concluded after 1 session – 
patient drops out without 
contact 
16.2 14 5.2 15.2 14 4.3 
Total 15.1 258 6.1 13.5 257 5.2 
 
                                                   
58 This is of all with recorded scores. 24 people who attended one or more sessions and are no longer 
in the system do not have an initial score recorded.  
59 There are 33 patients with only one session; of these 19 have an initial PHQ-9 or GAD-7 score 
recorded. Splitting these into types of conclusion results in one groups below the threshold of 
publishable data (Office of National Statistics guidelines advise suppressing results for cells with less 
than three individuals in them). 
60 Analysis using ANCOVA post-hoc test (Tukey HSD), excluding the category with insufficient sample 
size (those who concluded after 1 session by mutual agreement with the service). 
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x data suppressed – numbers below threshold of N=3 
* significantly different from ‘concluded after 1 session – patient drops out without 
contact’. 
 
 
Figure 4: Patient progress: Newham  
 
This leaves 249 who attended at least 2 sessions. As psychological well-being is 
monitored at each session, these patients have multiple PHQ-9 and/or GAD-7 
scores, allowing analysis of treatment outcomes. Further analysis will focus on this 
group and particularly on those who have been unwell for 6 months or more. 
 
This group of 249 is 58% of those who were referred, found suitable, and are no 
longer in the system. Prior duration of condition is known for 89% and 83% of these 
had been ill for over 6 months. Almost all had complete pre- and post-treatment test 
data. 
 
Among the 249, the average number of sessions was 8.2, comprising a total of 
around 7.2 hours of contact (including initial assessment session). The median time 
between sessions is 14 days. The median length of treatment from first session to 
last is 16 weeks (the mean is 18 weeks). 
 
The most common type of treatment ending among the 249 was concluding 
treatment in mutual agreement with the service (62%). 32% ended treatment by 
1,043 referred to system 
369 ‘concluded’ therapy 
249 attended at least 2 sessions 
0 status unknown 
385 still in system 
58 to employment service 
87 had no sessions  
33 had 1 session 
171 known to have 
been ill over 6 months 
and have pre- and post-
treatment PHQ-9 and/or 
GAD-7 records 
222 had the prior duration of their 
primary condition coded. Of these, 185 
(83%) had been ill over 6 months. 
812 suitable for the 
service 
231 unsuitable 
220 have pre- and post-
treatment PHQ9 and/or 
GAD7 records 
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dropping out (without contacting the service); 5% actively refuse further treatment, 
and 2% are referred on to other services. 
The most common activity was receiving step 3 full CBT from a specialist therapist, 
which was done by 183 of the 249 (74%). Among these patients, the mean number 
of CBT sessions was 7.3 (median was 7.0). 
 
Other activities include a range of so-called ‘step 2’ interventions, such as guided 
self-help, group psychosocial education, and CCBT. 42 of the 249 (17%) had done 
at least one session of such activities. The most common was guided self-help, done 
by 22 individuals; brief CBT (step 2b) was done by 6, and computerised CBT by 7. 
 
Among the 249, 36 received support from the employment service. 
 
Of course in a stepped care system patients can begin with lower step interventions 
and move to higher step interventions if needed. Of the 42 who had any step 2 
interventions (2a or 2b), 13 also had step 3 CBT, while 29 did not ‘step up’. This 
gives a rough step-up rate of 31%.61  
 
A more precise measure of step-up takes those who were cases at their last step 2a 
or 2b session, and asks what proportion went on to step 3 CBT. On this basis, the 
step-up rate is 32% (7 of 22). 
 
Of the 7 who did ‘step up’ on this latter measure, 4 completed treatment by mutual 
agreement with the service and 3 dropped out or terminated treatment early. 
 
Of the 15 who did not ‘step up’ on this latter measure, almost all (12) are recorded as 
having dropped out of treatment; of these, a third had step 2b (brief CBT) or step 3 
(full CBT) sessions scheduled which they failed to attend. The other 3 either had an 
ending mutually agreed with the service, or were referred on to other services. 
 
This analysis of step-up rates is based on relatively small numbers, since many step 
2 interventions (particularly 2a) were not delivered in earlier stages of the Newham 
IAPT demonstration site.  
                                                   
61 Note that this step-up rate includes people who received both step 2 and step 3, but in reverse 
order; there were 4 people who began with step 3 and later in their treatment also received some step 
2. 
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PSYCHOLOGICAL OUTCOMES 
 
The data on the psychological states of patients are based on paper questionnaires 
completed by patients at the start of each session. 
 
The benchmark for whether someone is clinically ill is normally set at scoring 10 or 
more on the PHQ-9, and/or 8 or over on the GAD-7 (Kroenke et al, 2002; 2007). 
Looking at such ‘cases’ only, 197 of the 220 for whom we have pre- and post-
treatment scores were ill at the beginning of their first session. Of these, 55% had 
recovered by the time they left the service. 
 
The change in the average score on each questionnaire is shown in Table 15. 
Another metric for judging psychological outcomes is effect sizes – the change in the 
average score on each questionnaire, divided by the pooled standard deviation. The 
effect sizes are 0.89 on the PHQ-9, 1.06 on the GAD-7, and 1.01 on the CORE-OM. 
 
 
Table 15: pre- and post-treatment scores for all 
 
  Pre Post 
PHQ-9 Mean (SD) 
 
N 
15.3 (6.2) 
 
221 
8.2 (7.2)  
 
221 
GAD-7 Mean (SD) 
 
N 
13.7 (5.1) 
 
221 
6.8 (5.8) 
 
221 
CORE-
OM 
Mean (SD) 
 
N 
1.83 (0.61) 
 
140 
1.07 (0.67) 
 
140 
 
The change in scores from pre- to post-treatment is significant for all measures.62 
 
 
Outcomes by duration 
 
Table 16 shows recovery rates, and table 17 pre- and post-treatment scores, both 
grouped by the prior duration of illness. 
 
The differences in recovery rates between the duration categories in Table 16 are 
not significant63. 
 
                                                   
62 For PHQ=9 F=172.985, p<0.0005; for GAD-7 F=250.152, p<0.0005; for COREOM: F=142.381, 
p<0.0005. 
63 Chi-square=5.682, p=0.224. Analysis included only those with prior duration of illness recorded. 
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Table 16: Recovery rates, by duration 
  
Prior problem duration % recovery N. of cases 
Under 6 months 72 32 
6 months – 1 year 67 12 
1-2 years 53 19 
2-4 years 60 35 
4+ years 49 89 
Missing duration data 20 10 
Total 55 197 
 
Note: this table includes only patients who are clinical cases, i.e. met the criteria of 
scoring 10 or over on at least one of the PHQ-9 or the GAD-7 at the initial meeting 
with the IAPT service.  
 
 
Table 17: pre- and post-treatment scores, by duration 
 
  PHQ-9 GAD-7 CORE-OM 
Problem 
duration 
 Pre Post Pre Post Pre Post 
Under 6 
months 
 15% 
 
Mean 
(SD) 
 
N 
14.8 
(5.6) 
 
35 
6.4
(6.2)
35
13.3
(4.9)
35
5.2
(4.7)
35
1.61 
(0.67) 
 
23 
0.95 
(0.49) 
 
23 
6 months – 
1 year 
 6% 
Mean 
(SD) 
 
N 
16.2 
(6.2) 
 
13 
5.3
(6.2)
13
14.6
(4.2)
 
13
4.2
(4.8)
13
1.84 
(0.28) 
 
9 
0.86 
(0.51) 
 
9 
1-2 years 
 10% 
Mean 
(SD) 
 
N 
15.1 
(7.3) 
 
23 
9.1
(9.4)
23
12.5
(5.9)
23
7.3
(7.7)
23
1.52 
(0.69) 
 
14 
0.69 
(0.83) 
 
14 
2-4 years 
 17% 
Mean 
(SD) 
 
N 
14.6 
(6.6) 
 
39 
7.4
(6.8)
39
13.8
(5.7)
39
6.0
(5.7)
39
1.86 
(0.70) 
 
25 
1.04 
(0.69) 
 
25 
4 years + 
 43% 
Mean 
(SD) 
 
N 
15.9 
(5.8) 
 
96 
8.9
(7.1)
96
14.1
(4.7)
96
7.4
(5.7)
96
2.01 
(0.50) 
 
65 
1.24 
(0.68) 
 
65 
Missing 
duration 
data 
 11% 
Mean 
(SD) 
 
N 
14.3 
(8.3) 
 
14 
12.0
(7.8)
14
12.4
(6.7)
14
10.3
(5.8)
14
0.95 
(0.18) 
 
4 
0.92 
(0.29) 
 
4 
Total Mean 
(SD) 
 
N 
15.3 
(6.2) 
 
220 
8.2
(7.2)
220
13.6
(5.1)
220
6.8
(5.8)
220
1.83 
(0.61) 
 
140 
1.07 
(0.67) 
 
140 
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The changes in scores over time (from pre- to post-treatment) are significant for all 
measures in Table 17.64 The interaction effects between time and duration are not 
significant for any of the measures. 
 
The IAPT Programme Board recommended that the Doncaster and Newham 
demonstration sites should not treat patients whose problem duration was less than 
six months65. The reasons for this are discussed in some detail in the ‘outcomes by 
duration’ section for Doncaster. The key point is that since natural recovery is 
common in recent onset cases of anxiety and depression in primary care, and in the 
absence of a randomised control group, results must be ‘benchmarked’ against 
standard data on recovery rates for this group separately. 
 
37 (17%) of the patients who have concluded treatment and attended 2 or more 
sessions had been unwell for less than 6 months at the start of treatment66. We will 
consider these individuals separately, after considering first the remaining 83% 
whose problem duration was greater than six months at the start of treatment. 
 
 
Long-term cases 
 
The literature suggests that natural recovery is low in patients where the prior 
problem duration is more than 6 months. Posternak and Miller (2001), in a meta-
analysis of wait-list control groups, found average recovery from depression was 
around 20%, and percentage change on the Beck Depression Inventory of 
approximately 16%. For anxiety disorders natural recovery appears even lower: wait-
list controls in randomised controlled trials for CBT for anxiety disorders rarely show 
recovery rates, for those who have been ill for more than six months, exceeding 5%. 
 
The Newham recovery rates and changes in symptom scores for the 83% of patients 
with prior duration of over six months comfortably exceed these benchmarks. 52% of 
the 165 patients who met initial caseness criteria recovered by the end of treatment. 
The effect sizes are 1.01 on the PHQ-9 and 1.24 on the GAD-7. It therefore seems 
reasonable to conclude that the treatment offered in the IAPT demonstration site is 
frequently effective in these cases.  
 
We know that at least 15% of the 165 were on medication and their recovery rate 
was 48%. The recovery rate of those known to be not taking medication was 33%. 
However, these rates are relatively unreliable due to the small numbers involved, 
n=25 and n=24 respectively.67 
 
The average number of contacts that took place for those who recovered was 
around 10 and for those who did not recover significantly lower (8)68. Similarly, the 
                                                   
64 GLM Repeated Measures. PHQ-9 F=132.47, p<0.0005; GAD-7 F=194.516, p<0.0005; CORE-OM 
F=101.513, p<0.0005. Analysis included only those with prior duration of illness recorded. 
65 Unless problem duration was at least 3 months and the person faced substantial risk to 
accommodation, employment or associated physical health due to their mental health condition. 
66 This is of those with duration data recorded; a further 27 (11% of the whole group who have 
concluded treatment and attended 2 or more sessions) did not have any duration data recorded. 
67 Note also the limitations in medication recording discussed on page 22.  
68 t=2.014, p=0.046.  
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average total contact time was higher for those who recovered (9 hours) than for 
those who did not (7.5 hours). 
  
Recovery rates differed somewhat according to primary condition. They were higher 
for anxiety disorders (59%) than for depression (51%).69 
 
 
Recent onset cases 
 
37 (17%) of the patients who have concluded treatment and attended 2 or more 
sessions had been unwell for less than 6 months at the start of treatment70. The 
recovery rate for those with prior duration under six months is 72%. This is similar to 
the upper end of those observed in the GP care alone conditions in Catalan et al 
(1984) and Kendrick et al (2006), as well as to the community recovery rates for 
recent onset depression in the Spijker et al (2002) and Tennant et al (1981) 
studies71. One cannot be confident that the intervention has been more effective for 
this group than what would have happened if the treatment was not being provided. 
 
As was noted in regard to Doncaster’s recent onset cases, benchmarking is a very 
rough way of establishing clinical effectiveness and it cannot give a firm conclusion – 
a randomised controlled trial showing equivalence would be needed for that. 
                                                   
69 For the small group of ‘other disorder’ the recovery rate was 50% (n=14). 
70 This is of those with duration data recorded; a further 27 (11% of the whole group who have 
concluded treatment and attended 2 or more sessions) did not have any duration data recorded. 
71 These studies are all outlined in further detail in the Doncaster section on recent onset cases. Note 
also that the Newham result is based on a relatively small sample size and so the results are not fully 
reliable. 
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EMPLOYMENT AND BENEFIT OUTCOMES 
 
Among people who concluded treatment and attended 2 or more sessions, the net 
increase of people at work corresponded to 10% of the treated population. This 
increase comes mainly from reducing numbers receiving Statutory Sick Pay (a 
decrease of 6%), and a decrease in numbers in the ‘other’ category (not employed, 
and not receiving benefits or SSP) of 4%. This is shown in table 18.72 
 
Most of the patients are long-term cases, and so results for those with prior condition 
duration of over six months are very similar, with a net increase in employment of 
7%, largely due to reducing numbers receiving Statutory Sick Pay. See table 19 for 
details. 
 
There are only 23 patients with recent onset (prior condition duration of under six 
months), so estimates are likely unreliable. They are detailed in table 20; the net 
increase in people at work is 22% of the group, due to a reduction in the number of 
benefit recipients of 9%, and a reduction of numbers receiving SSP of 13%. 
 
Incomplete employment questionnaires mean it is not possible to look at changes in 
sick days among the employed. 
 
 
Table 18: Changes in employment for all 
 
 Pre-treatment 
Benefit 
recipient 
(IB, IS, 
JSA)
Receiving 
Statutory 
Sick Pay
Employed 
(no SSP)
Other Total
Post-
treatment 
Benefit 
recipient 
(IB, IS, 
JSA) 
38 0 1 5 44
Receiving 
Statutory 
Sick Pay 
0 2 0 0 2
Employed 
(no SSP) 
2 6 54 8 70
Other 3 2 2 12 19
Total 43 10 57 25 135
 
                                                   
72 It was possible to compare employment outcomes in this group between those who had received 
support from the employment service and those who had not. Those who did receive support show a 
larger increase in net employment – 10.7% - compared to those who did not – 9.3%. Further analysis 
of the employment service was not undertaken, because their administrative records are not 
integrated with the main IAPT database (it is currently in the process of being integrated). 
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Table 19: Changes in employment for patients with over 6 months prior problem 
duration 
 
 Pre-treatment 
Benefit 
recipient 
(IB, IS, 
JSA)
Receiving 
Statutory 
Sick Pay
Employed 
(no SSP)
Other Total
Post-
treatment 
Benefit 
recipient 
(IB, IS, 
JSA) 
31 0 1 5 37
Receiving 
Statutory 
Sick Pay 
0 1 0 0 1
Employed 
(no SSP) 
1 4 44 6 55
Other 2 1 2 10 15
Total 34 6 47 21 108
 
 
Table 20: Changes in employment for patients with less than 6 months prior problem 
duration 
 
 Pre-treatment 
Benefit 
recipient 
(IB, IS, 
JSA)
Receiving 
Statutory 
Sick Pay
Employed 
(no SSP)
Other Total
Post-
treatment 
Benefit 
recipient 
(IB, IS, 
JSA) 
6 0 0 0 6
Receiving 
Statutory 
Sick Pay 
0 1 0 0 1
Employed 
(no SSP) 
1 2 8 2 13
Other 1 1 0 1 3
Total 8 4 8 3 23
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FOLLOW-UP SURVEY 
 
To fully evaluate the outcomes of the service it is important to determine if the 
psychological and employment gains achieved at the end of treatment are largely 
maintained over time. As the Newham IAPT service stops collecting any information 
on patients once they have their last treatment session, a one-off follow-up survey 
was carried out. 
 
Patients who had completed treatment by 1 September 2007, with at least two 
treatment sessions, were eligible for the follow-up survey. This was a total of 165 
people. 
 
The intention was to include all who had completed treatment at least three months 
previously. Delays in implementing the survey meant in practice it included all who 
had completed treatment at least four months previously. The average amount of 
time between last treatment session and the follow-up survey, for the full group, was 
42 weeks.73 
 
The follow-up survey consisted of three questionnaires – the PHQ-9, the GAD-7, and 
an employment status questionnaire (the same as were used during treatment). 
People were mailed the questionnaires for self-completion; those who did not return 
them were then phoned and offered the chance to complete them over the phone. 
 
Of the 165 surveyed, 60 people responded (36%). The respondents are 
representative of the full sample in terms of initial and final PHQ-9 and GAD-7, as 
well as prior duration of current condition74. 
 
Tables 21 and 22 show the psychological outcomes and Tables 23 and 24 the 
employment outcomes for, respectively, all respondents and those whose problem 
duration at start of treatment was six months or over75. 
 
 
Table 21: Psychological outcomes for all follow-up survey respondents 
 
  Pre Post Follow-up 
Recovery 
rate 
% 
 
N 
 57% 
 
51 
42% 
 
52 
PHQ-9 Mean (SD) 
 
N 
15.1 (6.6) 
 
59 
7.4 (6.4) 
 
59 
8.5 (6.8) 
 
59 
GAD-7 Mean (SD) 
 
N 
13.8 (5.3) 
 
59 
6.5 (5.2) 
 
59 
7.8 (5.9) 
 
59 
 
                                                   
73 The shortest amount of time was 17 weeks; the longest 74 weeks. 
74 Respondents have, on average, completed their treatment more recently than the full sample; the 
mean difference is 30 days, t=-2.647, p=0.010. 
75 See the section on psychological outcomes for discussion of the relationship between problem 
duration and outcomes. 
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Table 22: Psychological outcomes for follow-up survey respondents – respondents 
with 6 months or more prior problem duration 
 
  Pre Post Follow-up 
Recovery 
rate 
% 
 
N 
 64% 
 
39 
43% 
 
40 
PHQ-9 Mean (SD) 
 
N 
15.0 (6.4) 
 
44 
6.5 (5.7) 
 
44 
8.8 (7.0) 
 
44 
GAD-7 Mean (SD) 
 
N 
13.8 (4.9) 
 
44 
5.8 (4.8) 
 
44 
8.1 (6.2) 
 
44 
 
The changes in average PHQ-9 and GAD-7 scores are significant. At follow-up 
patients continue to have significantly lower PHQ and GAD scores than at pre-
treatment.76 For the overall group, the modest increases in PHQ & GAD scores from 
post-treatment to follow-up are not significant77; they are significant for the group 
who have had their condition for over six months78. 
 
 
Table 23: Changes in employment for all follow-up survey respondents 
 
 Pre-treatment 
Benefit 
recipient 
(IB, IS, 
JSA)
Receiving 
Statutory 
Sick Pay
Employed 
(no SSP)
Other Total
Follow-up Benefit 
recipient 
(IB, IS, 
JSA) 
14 0 1 5 20
Receiving 
Statutory 
Sick Pay 
0 0 3 0 3
Employed 
(no SSP) 
5 1 15 1 22
Other 2 0 2 8 12
Total 21 1 21 14 57
 
 
 
                                                   
76 For the overall group: on the PHQ-9, the change from pre-treatment to follow-up, F=32.10, 
p<0.0005; on the GAD-7, the change from pre-treatment to follow-up, F=40.765, p<0.0005. For the 
over six months prior duration group: on the PHQ-9, the change from pre-treatment to follow-up, 
F=21.696, p<0.0005; on the GAD-7, the change from pre-treatment to follow-up, F=26.967, p<0.0005. 
77 For PHQ-9, the change from post-treatment to follow-up: F=1.088, p=0.301. For GAD-7, the change 
from post-treatment to follow-up: F=2.048, p=0.158. 
78 For PHQ-9, the change from post-treatment to follow-up: F=4.124, p=0.048. For GAD-7, the change 
from post-treatment to follow-up: F=5.025, p=0.030. 
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Among the full group of respondents to the follow-up survey, the net increase in 
numbers employed is 1.8%. The net drop in benefit receipt is 1.8%. There is a net 
increase in numbers receiving Statutory Sick Pay of 3.5%.  
 
 
Table 24: Changes in employment for follow-up survey respondents with 6 months or 
more prior problem duration 
 
 Pre-treatment 
Benefit 
recipient 
(IB, IS, 
JSA)
Receiving 
Statutory 
Sick Pay
Employed 
(no SSP)
Other Total
Follow-up Benefit 
recipient 
(IB, IS, 
JSA) 
13 0 0 3 16
Receiving 
Statutory 
Sick Pay 
0 0 3 0 3
Employed 
(no SSP) 
5 1 11 1 18
Other 0 0 1 6 7
Total 18 1 15 10 44
 
Among the group of follow-up survey respondents who had previously had their 
condition for six months or more, the net increase in numbers employed is 6.8%, and 
the drop in benefit receipt is 4.5%. There is a net increase in numbers receiving 
Statutory Sick Pay of 4.5%. 
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FUNDING 
 
The demonstration sites went live in mid-August 2006. Between then and 30 
September 2007 expenditure on IAPT (excluding the additional provision in the 
existing primary care psychological service79) has been as follows80: 
 
 Actuals: 
Inception to Sept 07 
(~14 months) 
Budgeted:  
07/08 financial year 
(12 months) 
 Spend 
(£000)
Average 
FTE*
Budget 
(£000)
FTE  
Pay  
Clinical lead and deputy 117 1.1 145 1.4 
Senior/exp. CBT 
therapists 
350 5.0 315 6 
CBT therapists 38 1.4 112 3 
Assistant CBT therapists 84 3.2 181 6 
Project managers and 
administrators 
144 3.8 230 8 
   Pay total 734 982  
Non-Pay  
Training 51 50  
Facilities 122 77  
IT 118 3  
Advertising 7 0  
Other 82 86  
   Non-pay total 380 216  
Total cost of therapy 1114 1198  
Employment service 149 107  
Overall cost 1263 1305  
 
* Note: estimated - precise staffing levels have varied over the period. 
 
The overall spend on providing therapy was about £1,114,000. In addition £134K was spent 
on the employment service. Note that a proportion of spending to date will include start up 
costs and should not properly be included in the running cost of the IAPT service (this 
includes development of IT software and establishment of new premises). 
                                                   
79 The per annum budget for this is £163,000. The actuals from inception to September 2007 are 
lower (£156,715) as the additional provision took longer to begin than the main IAPT service. It funds 
1 therapist (systemic therapy) and 2 assistant therapists, and associated administration and 
management costs. Annex D gives patient data from the enhanced provision. 
80 The demonstration site went live mid-August 2006. The ‘Actuals’ column shows money spent over 
the 14 months from August 2006 to September 2007.  
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PUTTING THE SERVICE IN CONTEXT 
 
It is helpful to put this service in context. The population of Newham is 250,000, 
including 190,000 adults.81 From analysis of GP records (covering 60,000 adults), we 
find that in January – June 2007 2.0% of adults visited the GP with “a new record of 
depressive symptoms or other mental health problems” as diagnosed by the GP 
(Chan et al., 2008). This suggests an annual rate of new diagnoses of 4.0% - or 
7,600 people in the whole of Newham.82  
 
Of these, “new depressive symptoms” accounted for 50% of diagnoses. 
 
These figures for GP diagnoses, though much lower than in Doncaster, are larger 
than the combined number of patients referred to IAPT (1,043 over a 14-month 
period83) and existing psychological services (3,98684). However if we were to focus 
on cases where the patient had symptoms for over six months, we would find a 
higher proportion going to IAPT (though a specific calculation is not possible). 
 
IAPT itself was originally covering rather under one-third of the borough. But from 
March onwards it advertised throughout the borough for self-referrals and canvassed 
some other GP practices. The current rate of referral to IAPT at an annualised rate is 
around 1,300. But clearly the combination of Primary Care Psychology Services and 
IAPT still provides for only a proportion of patient need.  
 
IAPT achieves good results but unit costs have been high, because throughput has 
been lower than planned, due partly to the problems of start-up. 
                                                   
81 Latest available ONS mid-year estimate, for 2005. 
82 This compares with 8.3% in national data collected in 1991 for people aged 16-64 for people 
presenting with any new or ongoing mental health problem (National Mental Health Statistics). It also 
compares with 17% of the national adult population diagnosed as mentally ill in the Psychiatric 
Morbidity Survey of a representative sample of households in 2004. 
83 14 months is the approximate period covered by this report – from August 2006 to end September 
2007. 
84 This is to Tier 1 and Tier 2 services.  
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3. CONCLUDING OBSERVATIONS 
 
BACKGROUND 
 
Both demonstration sites have made substantial achievements over their first 
thirteen months against a background of considerable difficulties. These difficulties 
included an uncertain and delayed beginning of funding and no assurance of long-
term funding on the basis of which to recruit staff. That they have achieved what they 
have is a testament to the outstanding dedication and hard work of those involved. 
 
Both demonstration sites were new start-ups. The Doncaster site had existed in 
conception for about 12 months before it started. It hit the ground running and 
achieved a truly impressive level of throughput from the start.  
 
The Newham site had a standing start and initially it had serious organisational 
difficulties in obtaining sufficient referrals. Its throughput eventually increased but is 
still not as high as it should be, given its staffing. It has also undergone service 
redesign, putting more focus on step 2a services in phase two of the service 
delivery. It is anticipated that the increased emphasis on low intensity interventions 
will increase throughput in the future, as it has done in Doncaster. 
 
The clinical populations served by the sites are very different, as can be seen from 
Annex B. The Doncaster site focuses predominantly on individuals in whom 
depression is considered by GPs the main problem, whereas Newham focuses on 
depression and the full range of anxiety disorders. Individuals seen in Doncaster are 
predominantly white, whereas Newham has an ethnically mixed population with a 
significant number of individuals who do not speak English. Finally, a larger 
proportion of individuals seen in Newham have had their problem for more than 2 
years. 
 
 
ACHIEVEMENTS 
 
1. Numbers treated. An impressive number of people have been assessed and 
treated by the demonstration sites. During the thirteen months covered by this report 
(August 2006-September 2007) nearly 5,500 people have been referred to the two 
sites, of whom around 4,800 were considered suitable for the services. 
Approximately 3,500 of these individuals have now concluded their involvement with 
the services, with the remainder still in the system at September 2007. Of the 
concluded cases, around 1,900 have received at least 2 sessions of treatment with 
most having pre and post treatment scores on standardized outcome measures.  
The numbers seen in Doncaster are particularly impressive. 
 
2. Psychological benefits. In terms of therapeutic results both demonstration sites 
have achieved good recovery rates for people who have been sick for six months 
and more. Table 25 summarizes the recovery rates and mean changes in symptom 
scores. These results confirm that CBT in the field can deliver short-term 
therapeutic results well in line with those for clinical trials. Furthermore, the 
follow-up study suggests that these gains are largely maintained at between four 
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months and a year after treatment. Although similarly high recovery rates were 
obtained for people who had been unwell for less than 6 months, it is difficult to know 
whether this represents a significant benefit of treatment as natural recovery can 
also be high in such cases.  
 
 
Table 25: Recovery rates and changes in symptom scores to post-treatment and 
follow-up for all with over 6 months prior problem duration 
 
  To post-
treatment
To follow-up 
% recovery (cases) Doncaster 52% 40% 
Newham 52% 43% 
Change in average PHQ 
score (all) 
Doncaster -8.1 -5.4 
Newham -7.3 -6.2 
Change in average 
GAD-7 score (all) 
Doncaster -6.8 -4.8 
Newham -7.0 -5.7 
 
3. Employment effects. The effects on employment are also encouraging. The 
observed increase in employment of 5%85 of the treated population is supportive of 
the assumptions made in the cost-benefit analysis included in the Department of 
Health’s Comprehensive Spending Review proposal.  
 
4. Self-referral. Approximately one in five of the people seen in Newham referred 
themselves to the service. When compared with GP referrals, self-referral patients 
are at least as ill, tend to have had their problems for longer, and more closely 
matched the ethnic mix of the local population. In addition, some problems 
(social phobia and obsessive compulsive disorder) that were rare among GP 
referrals were more prominent among self-referrals. These findings show the 
potential of IAPT to reach sections of the population not adequately covered under 
present NHS arrangements. 
 
5. Outcome measurement. Data collection on psychological well-being 
measures that were given every session has been outstanding (see Annex A). 
This is in contrast to many existing psychological treatment services and suggests 
that a comprehensive system for monitoring outcomes in psychological well-being 
could be rolled out more broadly if it uses session by session recording and a 
computerized system (as in Doncaster). Data collection for clinical outcomes 
measures that were only administered at some sessions has been less good in both 
sites. There are some other serious omissions. Neither site has been good at 
recording medication – a particularly key issue in Doncaster as the collaborative care 
model puts strong emphasis on medication compliance (Gilbody et al, 2006). Final 
employment status is also only recorded in a quarter to a third of treated individuals. 
These omissions need to be addressed. 
 
                                                   
85 Average - combining Doncaster (4%) and Newham (10%). 
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ISSUES TO BE ADDRESSED 
 
1. NICE Guidelines. The two demonstration sites are works in progress. Despite 
their impressive achievements, neither can yet be described as comprehensive 
services that implement the NICE guidelines for the psychological treatment of 
depression and all the anxiety disorders. Newham covers the full range of problems 
but its early emphasis on high intensity treatment meant that it initially failed to reach 
the desired scale. Doncaster has focused more exclusively on those problems for 
which a stepped care model is particularly indicated and has placed a very strong 
emphasis on low intensity work (such as guided self-help). This has produced a high 
throughput but step up to high intensity CBT rarely occurred even in individuals who 
continued to meet caseness criteria at the end of low intensity work. Reasons for this 
need to be explored.  
 
NICE guidance varies between different disorders covered by the IAPT initiative. In 
order to decide which guidance is relevant for a particular person, a diagnosis needs 
to be established. In Newham CBT therapists conducted a diagnostic assessment. 
While this is likely to have established reliable diagnoses, it required a considerable 
amount of therapist time and hence adversely affected throughput. Doncaster did not 
use diagnostic interviews and relied on low intensity workers to conduct briefer 
person centred interviews. While this procedure helped throughput it seems likely 
that a more detailed assessment identifying a provisional diagnosis would have been 
needed if Doncaster had treated the full range of conditions that IAPT aims to cover. 
Further consideration needs to be given to how IAPT services can establish the 
diagnostic information necessary for implementing NICE guidance while at the same 
time ensuring the initial assessment process is reasonably streamlined.  
 
2. Measurement. The substantially higher data completeness rates for variables that 
were assessed every session suggests that the IAPT minimum data set should be 
reviewed to see if it would be possible to include very brief employment and disability 
assessments in the sessional measures. Greater consistency in recording 
medication is required. Systematic recording of onward referrals is also important. 
 
3. Follow-up. Depression is a recurring condition. Psychological treatments are 
particularly interesting as they bring with them the potential to achieve enduring 
change. However, neither site routinely follows up patients to determine whether 
gains have been maintained. We would recommend that the sites consider including 
a routine follow-up 3-6 months after treatment completion with the addition of a few 
booster sessions at that stage if there are signs of deterioration. The follow-up 
specially conducted for this report encouragingly showed that at 4-12 month follow-
up most of the psychological gains achieved during treatment were maintained (see 
Table 25). However, there was a modest amount of drop back that could perhaps 
have been reduced with a planned clinical follow-up and routinely including 
established relapse prevention procedures in the treatment programmes.  
 
4. Recent Onset Cases. It is reasonable to conclude that the treatment offered by 
the IAPT sites was frequently effective with people whose problems had persisted for 
six months or more. When shorter problem durations are considered, natural 
recovery rates in the absence of IAPT intervention could be high so we can be less 
sure that IAPT services provided added benefit. Research involving random 
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allocation to immediate treatment or treatment after a short delay is needed to clarify 
this point.  
 
In conclusion, both sites have demonstrated well the ability of psychological therapy 
services to help sections of the community hitherto neglected by the NHS. They have 
shown results in the field that are broadly in line with clinical trials and thus confirm the 
assumptions made in the IAPT business case. 
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ANNEX A:  
DATA COMPLETENESS AND RELATED ISSUES 
 
The data completeness rates for measures analysed in this report are given below.  
 
Most audits of clinical outcomes in NHS mental health services suffer from the 
problem that a substantial number of patients fail to complete measures at post 
treatment. Incomplete post-treatment data makes it difficult to draw clear-cut 
conclusions about the improvements that patients might expect to obtain if they are 
treated in a particular service. In an attempt to get round this problem, the two 
demonstration sites aimed to give simple measures of depression (PHQ) and anxiety 
(GAD) at every session. In this way,  it was hoped that it would be possible to obtain 
a post treatment symptom score on almost everyone. This is because if a patient 
drops out or the therapist forgets to give the measure at the formal post-treatment 
assessment, the score from the preceding session can be used as the post-
treatment score. As the tables below demonstrate, the system was successful. Both 
Demonstration sites achieved almost complete pre and post-treatment data for the 
PHQ and GAD. Lower post-treatment data completeness rates were observed for 
the measures (such as CORE-OM and the Employment Questionnaire) that were 
only meant to be given at pre-treatment, review and post-treatment. Follow-up data 
and information on medication usage also have substantial missing data.  
 
The fact that both sites obtained almost complete pre-post treatment data on the 
PHQ and GAD means that it is possible to compare the clinical outcomes of people 
who did and did not provide complete data on the CORE-OM and employment 
questionnaire. This allows one to determine whether the missing observations on 
these measures are a cause for concern. If the people who did and did not provide a 
post-treatment score on these measures show the same amount of improvement on 
the PHQ and GAD one could argue that the missing data is unlikely to have 
substantially distorted the picture. Unfortunately, this was not the case. Individuals 
who failed to provide post-treatment data on the CORE-OM or the  Employment 
Questionnaire tended to have shown less improvement on the PHQ and GAD (see 
below). This may be because they tended to have had less sessions of treatment 
before leaving the service. 
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DATA COMPLETENESS 
 
Doncaster initial and post-treatment data 
 
The data in this report come from the IAPT site’s own administrative database. The 
database software pre-existed the IAPT site – it has previously been used for other 
services in the UK and in the USA. 
 
There were a total of 2225 who were coded by the service as having ‘concluded’ 
treatment by the time of this report. For these, data completeness is as follows: 
 
 Patients with at 
least one 
session
Patients with 2 
or more 
sessions 
 No. % No. % 
Number 2225 - 1654 - 
Initial PHQ recorded 2217 100 1654 100 
Initial GAD recorded 2217 100 1654 100 
Initial CORE recorded 1639 74 1281 77 
Final PHQ recorded - - 1648 100 
Final GAD recorded - - 1648 100 
Final CORE recorded - - 92 6 
Initial employment status recorded 1859 84 1442 87 
Final employment status recorded - - 445 27 
Initial medication status recorded 1859 84 1422 86 
Final medication status recorded - - 0 0 
Duration of condition recorded 1648 74 1270 77 
 
Changes in medication status were not coded in the IAPT administrative data86. 
There is a partner code to initial medication status, which codes how long the patient 
has been taking the medication to date. This is completed for around 45% of patients 
who have initial medication status recorded. 
 
Doncaster has achieved outstanding data completeness for the measures (PHQ and 
GAD) that are given each session. Over 99%  of patients who had 2 or more 
sessions had both a pre and post treatment score. Data completeness for the 
measures (CORE and Employment) that are only scheduled for pre- and post-
treatment is considerably poorer (6% and 27% respectively).   
 
 
Doncaster follow-up data 
 
Patients who had completed treatment by 1 September 2007, with at least two 
treatment sessions, were eligible for the follow-up survey. This was a total of 1444 
people. Doncaster took a random sub-sample of 893 people from this group87. 
                                                   
86 It is possible that case managers used their free text notes to record changes in medication status. 
This has not been analysed. 
87 The sub-sample is representative of the full eligible group in terms of initial and final PHQ-9 and 
GAD-7 scores, and in terms of the prior duration of the current condition (no significant differences). 
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The follow-up survey consisted of three questionnaires – the PHQ-9, the GAD-7, and 
an employment status questionnaire (the same as were used during treatment). 
People were mailed the questionnaires, for self-completion; those who did not return 
them were then phoned and offered the chance to complete them over the phone. 
 
Of the 893 surveyed, 452 people responded (51%). Respondents had significantly 
lower final PHQ-9 and GAD-7 scores than non-respondents88. Data completeness 
for respondents is as follows: 
 
 Patients who responded to 
follow-up 
 No. % 
Number 452  
Initial PHQ recorded 452 100 
Initial GAD recorded 452 100 
Initial CORE recorded 377 83 
Final PHQ recorded 452 100 
Final GAD recorded 452 100 
Final CORE recorded 36 8 
Initial employment status recorded 393 87 
Final employment status recorded 108 24 
Initial medication status recorded 394 87 
Final medication status recorded 0 0 
Duration of condition recorded 365 81 
Follow-up PHQ recorded 435 96 
Follow-up GAD recorded 437 97 
Follow-up employment status 
recorded 
395 87 
 
 
Newham initial and post-treatment data 
 
The data in this report come from the IAPT site’s own administrative database. The 
database software was developed specifically for the service and delays in its 
implementation meant the service operated from paper systems for much of the 
period covered by this report. The subsequent switch from paper to IT-based 
systems raised some difficulties for data extraction; it is expected that data quality 
will continue to improve now the IT database is bedded in. 
 
Until recently the Newham IT system did not allow clinicians to give a positive code 
for ‘no medication taken’. This meant one cannot distinguish, from the database 
records, those known not to take medication from those for whom the information 
was not recorded89. The IT system has since been rectified. 
                                                   
88 One-way ANOVA: for PHQ-9, the mean difference was 1.33, F=0.7824, p=0.005; for GAD-7 the 
mean difference was 0.88, F=4.371, p=0.037. 
89 The Newham team state that they enquired about medication (and coded it if it was present) in 
almost all instances, which implies those without a medication record equals those not taking 
medication. 
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The IT system does allow recording of the date that medication stopped being taken 
(if any). Almost no patient has a medication end date recorded. It is unclear if this is 
because none ended medication while in treatment, or because clinicians failed to 
complete this data field. 
 
There were a total of 282 who were coded by the service as having ‘concluded’ 
treatment by the time of this report. For these, data completeness is as follows: 
 
 Patients with at 
least one 
session
Patients with 2 
or more 
sessions 
 No. % No. % 
Number 282 - 249 - 
Initial PHQ recorded 258 92 239 96 
Initial GAD recorded 257 91 238 96 
Initial CORE recorded 226 80 217 87 
Final PHQ recorded - - 220 88 
Final GAD recorded - - 220 88 
Final CORE recorded 140 56 
Initial employment status recorded 222 79 215 86 
Final employment status recorded - - 135 54 
Initial medication status recorded 90 32 86 35 
Final medication status recorded - - 0 0 
Duration of condition recorded 237 84 222 89 
 
Like Doncaster, Newham has achieved impressive data completeness for the 
measures (PHQ and GAD) that are given each session. Over 88%  of patients who 
had 2 or more sessions had pre- and post-treatment scores. This  is outstanding for 
a service in which 13% of users do not speak English. Data completeness for the 
measures (CORE and Employment) that are only scheduled for pre- and post-
treatment is less good (56% and 54% respectively). 
  
 
Newham follow-up data 
 
Patients who had completed treatment by 1 September 2007, with at least two 
treatment sessions, were eligible for the follow-up survey. This was a total of 165 
people. 
 
The follow-up survey consisted of three postal questionnaires – the PHQ-9, the 
GAD-7, and an employment status questionnaire. Those who did not return them 
were then phoned and offered the chance to complete them over the phone. 
 
Of the 165 surveyed, 60 people responded (36%). There were no significant 
differences between respondents and non-respondents in terms of initial or final 
PHQ-9 or GAD-7, or prior duration of current condition. Data completeness for 
respondents is as follows: 
 
 
  60
 Patients who responded to 
follow-up 
 No. % 
Number 60  
Initial PHQ recorded 60 100 
Initial GAD recorded 60 100 
Initial CORE recorded 58 97 
Final PHQ recorded 59 98 
Final GAD recorded 59 63 
Final CORE recorded 38 95 
Initial employment status recorded 57 62 
Final employment status recorded 37 27 
Initial medication status recorded 16 27 
Final medication status recorded 0 0 
Duration of condition recorded 54 90 
Follow-up PHQ recorded 60 100 
Follow-up GAD recorded 60 100 
Follow-up employment status 
recorded 
60 100 
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SIGNIFICANCE OF MISSING DATA 
 
Pre and post-treatment scores on the PHQ and GAD for individuals who did and did 
not provide pre and post treatment scores on the CORE-OM or the Employment 
Questionnaire are given below. Inspection of the means reveals that individuals who 
provided pre and post treatment scores on the CORE-OM or the Employment 
Questionnaire tended to have improved more than those who did not. This difference 
was significant (as indicated by a significant interaction effect in a mixed model 
ANOVA) for the Employment Questionnaire in both sites, for the CORE-OM in both 
sites when the GAD is used as the measure of clinical improvement and for Newham 
only when the PHQ is used as the measure of clinical improvement. 
 
A final table gives the pre-post effect sizes for the PHQ and GAD in individuals who 
did and did not have pre and post treatment scores on the CORE-OM and the 
Employment Questionnaire. The effect sizes for individuals who completed these 
measures at pre and post are on average 1.72 times greater than for those who did 
not (range 1.09 to 2.47). In general, the difference was larger in Newham than in 
Doncaster. The better depression and anxiety outcomes in individuals who 
completed pre and post-treatment CORE’s or Employment Questionnaires may be 
partly explained by the fact that they tend to have had more treatment sessions 
before leaving the services. The number of sessions they receive will be determined 
by patient choice or by mutual agreement between patient and therapist. 
 
Doncaster (CORE-OM) 
 
1. PHQ-9 
 
a. Descriptive statistics 
 
  Mean SD N 
First PHQ-9 
value 
Doesn’t have pre-post CORE 15.78 6.154 1556 
 Has pre-post CORE 15.37 6.249 92 
 Total 15.76 6.158 1648 
Last PHQ-9 
value 
Doesn’t have pre-post CORE 7.60 6.967 1556 
 Has pre-post CORE 6.01 6.389 92 
 Total 7.51 6.943 1648 
 
b. Tests of effects 
 
Time = pre-PHQ, post-PHQ 
CORE = whether had both pre- and post- scores for CORE, y/n 
 
  F d.f. Sig. 
Within-subjects Time 528.054 1 <0.0005 
 Time * CORE 2.388 1 0.122 
Between-
subjects 
CORE 2.877 1 0.09 
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2. GAD-7 
 
a. Descriptive statistics 
 
  Mean SD N 
First GAD-7 
value 
Doesn’t have pre-post CORE 13.79 5.155 1556 
 Has pre-post CORE 14.79 4.911 92 
 Total 13.84 5.146 1648 
Last GAD-7 
value 
Doesn’t have pre-post CORE 6.83 6.159 1556 
 Has pre-post CORE 6.03 6.310 92 
 Total 6.79 6.168 1648 
 
b. Tests of effects 
 
Time = pre-GAD-7, post-GAD-7 
CORE = whether had both pre- and post- scores for CORE, y/n 
 
  F d.f. Sig. 
Within-subjects Time 540.283 1 <0.0005 
 Time * CORE 7.145 1 0.008 
Between-
subjects 
CORE 0.041 1 0.840 
 
3. Difference in number of sessions 
 
Those who have both pre- and post-CORE have more sessions than those who do 
not (mean difference: 3.4 sessions (7.0 sessions versus 3.6 sessions) p=<0.0005). 
 
Doncaster (employment questionnaire) 
 
1. PHQ-9 
 
a. Descriptive statistics 
 
  Mean SD N 
First PHQ-9 
value 
Doesn’t have pre-post empl 15.59 6.233 1203 
 Has pre-post empl 16.21 5.933 445 
 Total 15.76 6.158 1648 
Last PHQ-9 
value 
Doesn’t have pre-post empl 8.11 7.158 1203 
 Has pre-post empl 5.90 6.045 445 
 Total 7.51 6.943 1648 
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b. Tests of effects 
 
Time = pre-PHQ, post-PHQ 
empl = whether had both pre- and post- scores for employment, y/n 
 
  F d.f. Sig. 
Within-subjects Time 2094.540 1 <0.0005 
 Time * empl 1299.714 1 <0.0005 
Between-
subjects 
empl 6.791 1 0.009 
 
2. GAD-7 
 
a. Descriptive statistics 
 
  Mean SD N 
First GAD-7 
value 
Doesn’t have pre-post empl 13.70 5.270 1203 
 Has pre-post empl 14.22 4.778 445 
 Total 13.84 5.146 1648 
Last GAD-7 
value 
Doesn’t have pre-post empl 7.27 6.353 1203 
 Has pre-post empl 5.50 5.439 445 
 Total 6.79 6.168 1648 
 
b. Tests of effects 
 
Time = pre-GAD-7, post-GAD-7 
empl = whether had both pre- and post- scores for employment, y/n 
 
  F d.f. Sig. 
Within-subjects Time 1921.675 1 <0.0005 
 Time * empl 43.595 1 <0.0005 
Between-
subjects 
empl 5.716 1 0.017 
 
3. Difference in number of sessions 
 
Those who have both pre- and post-employment have more sessions than those 
who do not (mean difference: 2.9 sessions (7.0 sessions versus 4.1 sessions) 
p=<0.0005). 
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Newham (CORE-OM) 
 
1. PHQ-9 
 
a. Descriptive statistics 
 
  Mean SD N 
First PHQ-9 
value 
Doesn’t have pre-post CORE 15.86 6.438 81 
 Has pre-post CORE 14.96 6.113 139 
 Total 15.30 6.235 220 
Last PHQ-9 
value 
Doesn’t have pre-post CORE 12.41 7.548 81 
 Has pre-post CORE 5.73 5.722 139 
 Total 8.19 7.202 220 
 
b. Tests of effects 
 
Time = pre-PHQ, post-PHQ 
CORE = whether had both pre- and post- scores for CORE, y/n 
 
  F d.f. Sig. 
Within-subjects Time 145.604 1 <0.0005 
 Time * CORE 30.193 1 <0.0005 
Between-
subjects 
CORE 28.187 1 <0.0005 
 
2. GAD-7 
 
a. Descriptive statistics 
 
  Mean SD N 
First GAD-7 
value 
Doesn’t have pre-post CORE 13.62 5.370 81 
 Has pre-post CORE 13.65 4.979 139 
 Total 13.64 5.115 220 
Last GAD-7 
value 
Doesn’t have pre-post CORE 9.99 6.302 81 
 Has pre-post CORE 4.91 4.603 139 
 Total 6.78 5.822 220 
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b. Tests of effects 
 
Time = pre-GAD-7, post-GAD-7 
CORE = whether had both pre- and post- scores for CORE, y/n 
 
  F d.f. Sig. 
Within-subjects Time 218.665 1 <0.0005 
 Time * CORE 37.393 1 <0.0005 
Between-
subjects 
CORE 17.916 1 <0.0005 
 
3. Difference in number of sessions 
 
Those who have both pre- and post-CORE have more sessions than those who do 
not (mean difference: 6.0 sessions (11.1 sessions versus 5.1 sessions), p=<0.0005). 
 
Newham (employment questionnaire) 
 
1. PHQ-9 
 
a. Descriptive statistics 
 
  Mean SD N 
First PHQ-9 
value 
Doesn’t have pre-post empl 15.91 6.335 85 
 Has pre-post empl 14.91 6.164 135 
 Total 15.30 6.235 220 
Last PHQ-9 
value 
Doesn’t have pre-post empl 11.68 7.697 85 
 Has pre-post empl 5.99 5.916 135 
 Total 8.19 7.202 220 
 
b. Tests of effects 
 
Time = pre-PHQ, post-PHQ 
empl = whether had both pre- and post- scores for employment, y/n 
 
  F d.f. Sig. 
Within-subjects Time 152.362 1 <0.0005 
 Time * empl 19.485 1 <0.0005 
Between-
subjects 
empl 21.804 1 <0.0005 
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2. GAD-7 
 
a. Descriptive statistics 
 
  Mean SD N 
First GAD-7 
value 
Doesn’t have pre-post empl 13.69 5.271 85 
 Has pre-post empl 13.61 5.033 135 
 Total 13.64 5.115 220 
Last GAD-7 
value 
Doesn’t have pre-post empl 9.35 6.367 85 
 Has pre-post empl 5.16 4.808 135 
 Total 6.78 5.822 220 
 
b. Tests of effects 
 
Time = pre-GAD-7, post-GAD-7 
empl = whether had both pre- and post- scores for employment, y/n 
 
  F d.f. Sig. 
Within-subjects Time 224.846 1 <0.0005 
 Time * empl 23.215 1 <0.0005 
Between-
subjects 
empl 12.893 1 <0.0005 
 
3. Difference in number of sessions 
 
Those who have both pre- and post-employment have more sessions than those 
who do not (mean difference: 5.8 sessions (11.2 sessions versus 5.4 sessions), 
p=<0.0005). 
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ANNEX B: PROFILES OF REFERRED PATIENTS 
 
 Doncaster  Newham 
Gender: (%) (%) 
Female 65 60 
Male 35 40 
Ethnicity*:   
White 99.5 51 
Asian 0.2 25 
Black 0.1 17 
Mixed <0.1 4 
Chinese or other ethnic group <0.1 3 
Other / do not know 0.1 - 
Age:   
18-24 16 13 
25-44 52 58 
45-64 28 25 
Do not speak English: 0 13 
Primary diagnosis:   
Depression** 95 46 
Anxiety disorders** 5 43 
- General anxiety 
disorder 
3.9 6 
- Agoraphobia ‘no panic’ 0.1 - 
- Agoraphobia ‘with 
panic’ 
0.4 - 
- Agoraphobia - 3 
- Panic disorder - 6 
- Social phobia 0.3 5 
- Specific phobia <0.1 1 
- PTSD 0.1 5 
- OCD 0.1 4 
- Health anxiety <0.1 3 
- Other anxiety disorder 0 10 
Other conditions 1 12 
Prior length of current episode:   
Less than 6 months 33 22 
6 months to 2 years 33 17 
2 years or more 34 61 
 
* These figures are calculated excluding the ‘missing’ category. Doncaster had none 
missing, Newham had 9% of the total referred group missing ethnicity data. 
** For comparison, the relative rates of GP detection of these two classes of 
disorders are as follows: 
Newham: 69% depression to 31% anxiety disorders 
Doncaster: 79% depression to 21% anxiety disorders 
(Chan et al, 2008) 
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ANNEX C: GP PRACTICE DATA 
 
Data from GP practices in Doncaster and Newham were extracted and analysed by 
the Primary Care Informatics team at St George’s, University of London – see Chan 
et al. (2008) for details. Key findings for each site are summarised below. 
 
 Doncaster Newham 
Proportion of practice adults with new depressive 
symptoms in first 6 months of 2007 
 
3.21 0.96 
Proportion of practice adults with new depressive 
or other mental health problem in first 6 months of 
2007 
 
5.47 1.97 
Proportion of practice adults with prescriptions of 
antidepressants, anxiolytics or hypnotics in the first 
6 months of 2007 
8.87 5.16 
Proportion of practice adults with mental health 
problems receiving sick notes in the first six months 
of 2007  
1.89 0.82 
 
The team also analysed total prescriptions of antidepressant drugs for the Doncaster 
and Newham PCTs compared to the national rate in 2006-07: the national level of 
prescriptions per thousand adult population is 762.4; Newham, with 445.8 
prescriptions per thousand adults, has a lower prescribing rate; Doncaster, with 
985.5 prescriptions per thousand adults has a higher prescribing rate. 
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ANNEX D: OUTCOMES BY ETHNICITY 
 
Newham is an ethically mixed borough. By utilizing self-referral, the IAPT service 
was able to attract an increased proportion of patients from BME groups (see page 
34).  In this Annex we ask whether the outcomes of individuals in the IAPT service 
were related to ethnicity. Details of the relevant analyses are given below. The broad 
answer is that ethnicity did not appear to influence outcome. Patients from BME 
groups who were treated in the service achieved at least as good outcomes as non-
BME patients. This suggests that the Newham service (which included staff from 
BME groups: see page 32) was successful in equitably meeting the needs of its 
ethnically diverse population.  
 
 
Cohort 
 
There are 247 people who can be analysed (i.e. have had 2 or more sessions of 
therapy, had completed by September 2007 and have ethnicity recorded).90  
 
The ethnic distribution is as follows: 
• White = 134 (54%) 
• Asian / Asian British = 67 (27%) 
• Black / Black British) = 33 (13%) 
• Other = 13 (5%)91  
 
All significance tests are conducted twice – once with all four ethnic groups, once 
with only the 3 largest ethnic groups (to check the small numbers in the final group 
are not skewing results). 
 
 
Recovery rates 
 
Proportion of people who were cases initially and who were no longer cases by end 
of treatment92:  
 
Ethnic group % recovery N. of cases 
White 50.5 119 
Asian / Asian British 66.7 57 
Black / Black British 54.2 30 
Other 50.0 13 
 
Recovery rates do not vary significantly by ethnic group93. 
                                                   
90 Ethnicity recording is excellent – there are only 2 people who have to be excluded from the analysis 
because of unknown ethnicity. 
91 This group combines two categories - Chinese and other, and Mixed – because of the small 
numbers in these groups (Chinese and other = 7, Mixed = 6).  
92 To qualify as a case, person must score 8 or over on the GAD7 or 10 or over on the PHQ9 (or 
both). Recovery means dropping below both on GAD7 and 10 on PHQ9. Only cases who completed 
GAD7 and PHQ9 at pre and post are included. 
93 Chi-square=3.842, p=0.279. For the three main groups only, chi-square=3.712, p=0.156.. 
  70
Changes in scores 
 
  PHQ-9 GAD-7 
Ethnicity  Pre Post Pre Post
White 
 
Mean 
(SD) 
 
N 
15.85 
(6.06) 
 
119 
8.24
(6.85)
119
13.87
(5.20)
119
7.01
(5.81)
119
Asian Mean 
(SD) 
 
N 
14.65 
(6.35) 
 
57 
7.37
(7.32)
57
13.91
(5.10)
 
57
5.77
(5.56)
57
Black Mean 
(SD) 
 
N 
13.83 
(7.17) 
 
30 
8.23
(7.34)
30
12.17
(5.19)
30
6.73
(5.70)
30
Other Mean 
(SD) 
 
N 
16.77 
(4.64) 
 
13 
10.77
(9.58)
13
14.00
(4.22)
13
8.92
(7.27)
13
Total Mean 
(SD) 
 
N 
15.32 
(6.24) 
 
219 
8.16
(7.21)
219
13.65
(5.12)
219
6.76
(5.83)
219
 
Initial PHQ9 and GAD7 scores do not vary significantly by ethnic group94.  
 
Changes in scores (post-treatment) do not vary significantly by ethnic group95. 
 
 
Range of disorders 
 
 Condition 
Ethnicity  Depression Anxiety Other 
White 52%  40% 9% 
Asian 38% 53% 10% 
Black  50% 29% 21% 
Other 46% 46% 8% 
 
 There is no significant difference, by ethnic group, in the distribution of disorders96. 
 
 
 
                                                   
94 Oneway ANOVA. For all four groups, p=0.241 and p=0.428 for PHQ9 and GAD7 respectively. For 
the three main groups, p=0.210 and p= 0.273 for PHQ9 and GAD7 respectively. 
95 Repeated measures GLM. Interaction between group ant time (pre-post): For all four groups, 
p=0.616 and p=0.198 for PHQ9 and GAD7 respectively. For the three main groups, p=0.472 and 
p=0.165 respectively. 
96 Likelihood Ratio. For all four groups, p=0.252. For the three main groups, p=0.106. 
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Duration of current episode 
 
Prior duration of current episode: 
• White = 8.37 (mean years), 4.54 (median years) 
• Asian = 5.36 (mean years), 2.83 (median years) 
• Black = 6.79 (mean years), 2.50 (median years) 
• Other = 3.36 (mean years), 1.50 (median years) 
 
The differences are not significant for either all four ethnic categories or for the three 
largest categories97. 
 
 
Breaking down into duration categories: 
 
 Ethnicity 
Duration White Asian Black Other 
< 6 months 15% 8% 27% 23% 
6 months – 1 year 4% 9% 3% 8% 
1-2 years 11% 8% 3% 23% 
2-4 years 12% 30% 12% 8% 
4+ years 48% 37% 37% 39% 
Missing data 10% 9% 18% 0% 
  
The differences in duration categories between ethnic groups are significant98. 
 
                                                   
97 One-way ANOVA. For all four groups, p=0.053. For the three main groups, p=0.086. 
98 Likelihood Ratio. For all four groups, p=0.024. For the three main groups only, p=0.010. Analysis 
included only those with prior duration of illness recorded. 
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